sncr-202503310001131554FALSEDecember 312025Q1http://synchronoss.com/20250331#HanoverRateMemberhttp://fasb.org/us-gaap/2024#AccruedLiabilitiesCurrenthttp://fasb.org/us-gaap/2024#AccruedLiabilitiesCurrenthttp://synchronoss.com/20250331#LeaseLiabilityNoncurrenthttp://synchronoss.com/20250331#LeaseLiabilityNoncurrenthttp://fasb.org/us-gaap/2024#AccruedLiabilitiesCurrenthttp://fasb.org/us-gaap/2024#AccruedLiabilitiesCurrenthttp://synchronoss.com/20250331#LeaseLiabilityNoncurrenthttp://synchronoss.com/20250331#LeaseLiabilityNoncurrenthttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrMember33.3333.3333.3333.3333.3333.33xbrli:sharesiso4217:USDiso4217:USDxbrli:sharesxbrli:puresncr:segmentsncr:notesncr:votesncr:compensation_plansncr:defendant00011315542025-01-012025-03-310001131554us-gaap:CommonStockMember2025-01-012025-03-310001131554sncr:EightPointThreeSevenFivePercent2500ParValueSeniorNotesDue2026Member2025-01-012025-03-3100011315542025-05-0500011315542025-03-3100011315542024-12-3100011315542024-01-012024-03-310001131554us-gaap:CommonStockMember2024-12-310001131554us-gaap:AdditionalPaidInCapitalMember2024-12-310001131554us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-12-310001131554us-gaap:RetainedEarningsMember2024-12-310001131554us-gaap:AdditionalPaidInCapitalMember2025-01-012025-03-310001131554us-gaap:CommonStockMember2025-01-012025-03-310001131554us-gaap:RetainedEarningsMember2025-01-012025-03-310001131554us-gaap:AccumulatedOtherComprehensiveIncomeMember2025-01-012025-03-310001131554us-gaap:CommonStockMember2025-03-310001131554us-gaap:AdditionalPaidInCapitalMember2025-03-310001131554us-gaap:AccumulatedOtherComprehensiveIncomeMember2025-03-310001131554us-gaap:RetainedEarningsMember2025-03-310001131554us-gaap:CommonStockMember2023-12-310001131554us-gaap:AdditionalPaidInCapitalMember2023-12-310001131554us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-12-310001131554us-gaap:RetainedEarningsMember2023-12-3100011315542023-12-310001131554us-gaap:AdditionalPaidInCapitalMember2024-01-012024-03-310001131554us-gaap:CommonStockMember2024-01-012024-03-310001131554us-gaap:RetainedEarningsMember2024-01-012024-03-310001131554us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-01-012024-03-310001131554us-gaap:CommonStockMember2024-03-310001131554us-gaap:AdditionalPaidInCapitalMember2024-03-310001131554us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-03-310001131554us-gaap:RetainedEarningsMember2024-03-3100011315542024-03-310001131554us-gaap:SeriesBPreferredStockMember2025-01-012025-03-310001131554us-gaap:SeriesBPreferredStockMember2024-01-012024-03-310001131554srt:NorthAmericaMember2025-01-012025-03-310001131554srt:NorthAmericaMember2024-01-012024-03-310001131554srt:AsiaPacificMember2025-01-012025-03-310001131554srt:AsiaPacificMember2024-01-012024-03-310001131554us-gaap:EMEAMember2025-01-012025-03-310001131554us-gaap:EMEAMember2024-01-012024-03-310001131554sncr:ProfessionalServicesMember2025-01-012025-03-310001131554sncr:ProfessionalServicesMember2024-01-012024-03-310001131554sncr:SubscriptionServicesMember2025-01-012025-03-310001131554sncr:SubscriptionServicesMember2024-01-012024-03-310001131554us-gaap:LicenseMember2025-01-012025-03-310001131554us-gaap:LicenseMember2024-01-012024-03-3100011315542025-04-012025-03-310001131554us-gaap:OperatingSegmentsMembersncr:ReportableSegmentMember2025-01-012025-03-310001131554us-gaap:OperatingSegmentsMembersncr:ReportableSegmentMember2024-01-012024-03-310001131554us-gaap:CorporateNonSegmentMembersncr:ReportableSegmentMember2025-01-012025-03-310001131554us-gaap:CorporateNonSegmentMembersncr:ReportableSegmentMember2024-01-012024-03-310001131554sncr:ReportableSegmentMember2025-01-012025-03-310001131554sncr:ReportableSegmentMember2024-01-012024-03-310001131554sncr:AccountsReceivableSecuritizationFacilityMember2022-06-230001131554sncr:AccountsReceivableSecuritizationFacilityMember2022-06-232022-06-230001131554sncr:AccountsReceivableSecuritizationFacilityMember2025-01-012025-03-310001131554sncr:AccountsReceivableSecuritizationFacilityMember2024-01-012024-03-310001131554sncr:AccountsReceivableSecuritizationFacilityMembersncr:SNTechnologiesMember2025-03-310001131554sncr:AccountsReceivableSecuritizationFacilityMember2025-03-310001131554sncr:AccountsReceivableSecuritizationFacilityMemberus-gaap:SubsequentEventMember2025-04-212025-04-210001131554us-gaap:FairValueInputsLevel1Member2025-03-310001131554us-gaap:FairValueInputsLevel2Member2025-03-310001131554us-gaap:FairValueInputsLevel3Member2025-03-310001131554us-gaap:FairValueInputsLevel1Member2024-12-310001131554us-gaap:FairValueInputsLevel2Member2024-12-310001131554us-gaap:FairValueInputsLevel3Member2024-12-310001131554sncr:SequentialTechnologyInternationalLLCAndAPCapitalHoldingsIILLCMemberus-gaap:LoansPayableMember2020-06-300001131554sncr:SequentialTechnologyInternationalLLCAndAPCapitalHoldingsIILLCMember2022-12-310001131554sncr:SequentialTechnologyInternationalLLCAndAPCapitalHoldingsIILLCMembersncr:PromissoryNoteMember2024-03-310001131554sncr:SequentialTechnologyInternationalLLCAndAPCapitalHoldingsIILLCMembersncr:PromissoryNoteMember2025-01-082025-01-080001131554sncr:A2024TermLoanMemberus-gaap:LineOfCreditMember2024-06-280001131554sncr:SeniorNotes8.375DueJune302026Memberus-gaap:SeniorNotesMember2021-06-300001131554sncr:A2024TermLoanMemberus-gaap:LineOfCreditMember2024-06-282024-06-280001131554sncr:A2024TermLoanMemberus-gaap:LineOfCreditMembersncr:PeriodOneMember2024-06-282024-06-280001131554sncr:A2024TermLoanMemberus-gaap:LineOfCreditMembersncr:PeriodTwoMember2024-06-282024-06-280001131554sncr:TermLoanFacilityMember2025-01-012025-03-3100011315542024-06-282024-06-280001131554us-gaap:SeriesBPreferredStockMember2024-06-280001131554sncr:SeniorNotes8.375DueJune302026Memberus-gaap:SeniorNotesMembersncr:BRPIMember2024-06-280001131554sncr:SeniorNotes8.375DueJune302026Memberus-gaap:SeniorNotesMember2024-06-280001131554sncr:SeniorNotes8.375DueJune302026Memberus-gaap:SeniorNotesMember2021-06-302021-06-300001131554sncr:SeniorNotes8.375DueJune302026Memberus-gaap:SeniorNotesMemberus-gaap:DebtInstrumentRedemptionPeriodOneMember2021-06-302021-06-300001131554sncr:SeniorNotes8.375DueJune302026Memberus-gaap:SeniorNotesMemberus-gaap:DebtInstrumentRedemptionPeriodTwoMember2021-06-302021-06-300001131554sncr:SeniorNotes8.375DueJune302026Memberus-gaap:SeniorNotesMemberus-gaap:DebtInstrumentRedemptionPeriodThreeMember2021-06-302021-06-300001131554sncr:SeniorNotes8.375DueJune302026Memberus-gaap:SeniorNotesMember2021-10-250001131554sncr:SeniorNotes8.375DueJune302026Memberus-gaap:SeniorNotesMember2021-10-252021-10-250001131554sncr:SeniorNotes8.375DueJune302026Memberus-gaap:SeniorNotesMember2021-12-310001131554sncr:TermLoanMemberus-gaap:SubsequentEventMembersncr:TPBirchGroveMember2025-04-240001131554sncr:TermLoanMemberus-gaap:SubsequentEventMembersncr:TPBirchGroveMember2025-04-242025-04-240001131554sncr:SeniorNotes8.375DueJune302026Memberus-gaap:SeniorNotesMember2025-03-310001131554sncr:SeniorNotes8.375DueJune302026Memberus-gaap:SeniorNotesMember2024-12-310001131554sncr:A2024TermLoanMemberus-gaap:LineOfCreditMember2025-03-310001131554sncr:A2024TermLoanMemberus-gaap:LineOfCreditMember2024-12-310001131554sncr:SeniorNotes8.375DueJune302026Memberus-gaap:SeniorNotesMember2025-01-012025-03-310001131554sncr:SeniorNotes8.375DueJune302026Memberus-gaap:SeniorNotesMember2024-01-012024-03-310001131554sncr:A2024TermLoanMember2025-01-012025-03-310001131554sncr:A2024TermLoanMember2024-01-012024-03-310001131554us-gaap:AccumulatedTranslationAdjustmentMember2024-12-310001131554us-gaap:AccumulatedTranslationAdjustmentMember2025-01-012025-03-310001131554us-gaap:AccumulatedTranslationAdjustmentMember2025-03-310001131554sncr:AccumulatedNetGainLossOnIntraEntityForeignCurrencyTransactionsMember2024-12-310001131554sncr:AccumulatedNetGainLossOnIntraEntityForeignCurrencyTransactionsMember2025-01-012025-03-310001131554sncr:AccumulatedNetGainLossOnIntraEntityForeignCurrencyTransactionsMember2025-03-310001131554us-gaap:PreferredStockMember2025-03-310001131554us-gaap:SeriesBPreferredStockMemberus-gaap:PrivatePlacementMember2021-06-302021-06-300001131554us-gaap:SeriesBPreferredStockMember2021-06-300001131554sncr:EquityIncentivePlan2015Member2025-03-310001131554sncr:NewHireEquityIncentivePlan2017Member2025-03-310001131554sncr:PerformanceBasedCashUnitsMember2025-01-012025-03-310001131554sncr:PerformanceBasedCashUnitsMembersncr:PerformanceBasedCashUnitsMember2025-01-012025-03-310001131554sncr:PerformanceBasedCashUnitsMembersncr:EquityIncentivePlan2015Member2025-03-310001131554us-gaap:CostOfSalesMember2025-01-012025-03-310001131554us-gaap:CostOfSalesMember2024-01-012024-03-310001131554us-gaap:ResearchAndDevelopmentExpenseMember2025-01-012025-03-310001131554us-gaap:ResearchAndDevelopmentExpenseMember2024-01-012024-03-310001131554us-gaap:SellingGeneralAndAdministrativeExpensesMember2025-01-012025-03-310001131554us-gaap:SellingGeneralAndAdministrativeExpensesMember2024-01-012024-03-310001131554sncr:EmployeeAndDirectorsStockOptionsMember2025-01-012025-03-310001131554sncr:EmployeeAndDirectorsStockOptionsMember2024-01-012024-03-310001131554us-gaap:RestrictedStockMember2025-01-012025-03-310001131554us-gaap:RestrictedStockMember2024-01-012024-03-310001131554sncr:PerformanceBasedCashUnitsMember2024-01-012024-03-310001131554sncr:PerformanceBasedCashUnitsMember2025-03-310001131554sncr:EmployeeAndDirectorsStockOptionsMemberus-gaap:ShareBasedCompensationAwardTrancheOneMember2025-01-012025-03-310001131554sncr:EmployeeAndDirectorsStockOptionsMemberus-gaap:ShareBasedCompensationAwardTrancheTwoMember2025-01-012025-03-310001131554sncr:EmployeeAndDirectorsStockOptionsMemberus-gaap:ShareBasedCompensationAwardTrancheThreeMember2025-01-012025-03-310001131554us-gaap:RestrictedStockMemberus-gaap:ShareBasedCompensationAwardTrancheTwoMember2025-01-012025-03-310001131554us-gaap:RestrictedStockMemberus-gaap:ShareBasedCompensationAwardTrancheThreeMember2025-01-012025-03-310001131554us-gaap:RestrictedStockMemberus-gaap:ShareBasedCompensationAwardTrancheOneMember2025-01-012025-03-310001131554us-gaap:EmployeeSeveranceMember2024-12-310001131554us-gaap:EmployeeSeveranceMember2025-01-012025-03-310001131554us-gaap:EmployeeSeveranceMember2025-03-310001131554us-gaap:PerformanceSharesMember2025-01-012025-03-310001131554us-gaap:PerformanceSharesMember2024-01-012024-03-310001131554sncr:OptionsAndUnvestedRestrictedSharesMember2025-01-012025-03-310001131554sncr:OptionsAndUnvestedRestrictedSharesMember2024-01-012024-03-3100011315542022-06-072022-06-0700011315542024-04-012024-06-300001131554sncr:CreditAgreementFirstAmendmentMembersncr:TermLoanMemberus-gaap:SubsequentEventMember2025-04-240001131554sncr:CreditAgreementFirstAmendmentMembersncr:TermLoanMemberus-gaap:SubsequentEventMember2025-04-242025-04-240001131554sncr:CreditAgreementFirstAmendmentMemberus-gaap:SeniorNotesMemberus-gaap:SubsequentEventMember2025-04-242025-04-240001131554sncr:CreditAgreementFirstAmendmentMemberus-gaap:SubsequentEventMember2025-04-242025-04-240001131554sncr:CreditAgreementFirstAmendmentMemberus-gaap:SubsequentEventMembersrt:MinimumMember2025-04-242025-04-240001131554sncr:CreditAgreementFirstAmendmentMemberus-gaap:SubsequentEventMembersrt:MaximumMember2025-04-242025-04-24
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-Q
(Mark One) | | | | | |
☒ | QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
For the quarterly period ended March 31, 2025
Or | | | | | |
☐ | TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
For the transition period from to
Commission file number 001-40574
SYNCHRONOSS TECHNOLOGIES, INC.
(Exact name of registrant as specified in its charter) | | | | | |
Delaware | 06-1594540 |
(State or other jurisdiction of incorporation or organization) | (I.R.S. Employer Identification No.) |
| |
200 Crossing Boulevard, 8th Floor Bridgewater, New Jersey | 08807 |
(Address of principal executive offices) | (Zip Code) |
(866) 620-3940
(Registrant’s telephone number, including area code)
(Former name, former address, and former fiscal year, if changed since last report)
Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes x No ¨
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes x No ¨
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, or a non-accelerated filer. See definition of “accelerated filer and large accelerated filer” in Rule 12b-2 of the Exchange Act. (Check one):
| | | | | | | | | | | | | | |
Large accelerated filer | ☐ | | Accelerated filer | x |
Non-accelerated filer | ☐ | | Smaller Reporting Company | ☐ |
Emerging growth company | ☐ | | | |
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No x
Securities registered pursuant to Section 12(b) of the Act: | | | | | | | | | | | | | | |
Title of each class | | Trading Symbol(s) | | Name of each exchange on which registered |
Common Stock, $.0001 par value
| | SNCR | | The Nasdaq Stock Market, LLC
|
8.375% Senior Notes due 2026 | | SNCRL | | The Nasdaq Stock Market, LLC |
As of May 5, 2025, there were 11,497,976 shares of common stock issued and outstanding.
SYNCHRONOSS TECHNOLOGIES, INC.
FORM 10-Q INDEX
PART I. FINANCIAL INFORMATION
ITEM 1. CONDENSED CONSOLIDATED FINANCIAL STATEMENTS AND NOTES
SYNCHRONOSS TECHNOLOGIES, INC.
CONDENSED CONSOLIDATED BALANCE SHEETS
(Unaudited) (In thousands)
| | | | | | | | | | | | | | | |
| | March 31, 2025 | | December 31, 2024 | |
ASSETS | | | | | |
Current assets: | | | | | |
Cash and cash equivalents | | $ | 29,138 | | | $ | 33,375 | | |
| | | | | |
| | | | | |
Accounts receivable, net | | 19,286 | | 18,129 | |
Prepaid & other current assets | | 29,781 | | 29,878 | |
| | | | | |
| | | | | |
Total current assets | | 78,205 | | 81,382 | |
Non-current assets: | | | | | |
| | | | | |
Property and equipment, net | | 3,280 | | 3,154 | |
Operating lease right-of-use assets | | 7,900 | | 8,445 | |
Goodwill | | 182,378 | | 179,408 | |
Intangible assets, net | | 19,135 | | 19,117 | |
| | | | | |
| | | | | |
Other assets, non-current | | 2,438 | | 2,319 | |
| | | | | |
| | | | | |
Total non-current assets | | 215,131 | | 212,443 | |
Total assets | | $ | 293,336 | | | $ | 293,825 | | |
LIABILITIES AND STOCKHOLDERS’ EQUITY | | | | | |
Current liabilities: | | | | | |
Accounts payable | | $ | 4,158 | | | $ | 7,067 | | |
Accrued expenses | | 31,515 | | 30,519 | |
Deferred revenues, current | | 600 | | 837 | |
Debt, current | | 1,875 | | 1,875 | |
| | | | | |
| | | | | |
Total current liabilities | | 38,148 | | 40,298 | |
| | | | | |
| | | | | |
| | | | | |
Long-term debt, net of debt issuance costs | | 185,166 | | 184,840 | |
Deferred tax liabilities | | 3,279 | | 4,903 | |
| | | | | |
| | | | | |
Leases, non-current | | 15,394 | | 16,776 | |
Other liabilities, non-current | | 3,411 | | 4,733 | |
Total liabilities | | 245,398 | | 251,550 | |
Commitments and contingencies: | | | | | |
| | | | | |
Redeemable non-controlling interest | | 12,500 | | 12,500 | |
Stockholders’ equity: | | | | | |
Common stock, $0.0001 par value; 16,667 and 16,667 shares authorized, 11,498 and 11,075 shares issued and outstanding at March 31, 2025 and December 31, 2024, respectively | | 1 | | 1 | |
| | | | | |
Additional paid-in capital | | 496,533 | | 495,906 | |
Accumulated other comprehensive loss | | (32,284) | | (41,137) | |
Accumulated deficit | | (428,812) | | (424,995) | |
Total stockholders’ equity | | 35,438 | | 29,775 | |
Total liabilities and stockholders’ equity | | $ | 293,336 | | | $ | 293,825 | | |
See accompanying notes to condensed consolidated financial statements.
SYNCHRONOSS TECHNOLOGIES, INC.
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(Unaudited) (In thousands, except per share data)
| | | | | | | | | | | | | | | | | | | | | | |
| | Three Months Ended March 31, | | | | |
| | 2025 | | 2024 | | | | | | | | |
| | | | | | | | | | | | |
| | | | | | | | | | | | |
Net revenues | | $ | 42,213 | | | $ | 42,965 | | | | | | | | | |
Costs and expenses: | | | | | | | | | | | | |
Cost of revenues1 | | 8,711 | | | 10,223 | | | | | | | | | |
Research and development | | 9,698 | | | 10,331 | | | | | | | | | |
Selling, general and administrative | | 11,379 | | | 13,257 | | | | | | | | | |
Restructuring charges | | 118 | | | 219 | | | | | | | | | |
Depreciation and amortization | | 4,078 | | | 4,359 | | | | | | | | | |
Total costs and expenses | | 33,984 | | | 38,389 | | | | | | | | | |
Income from operations | | 8,229 | | | 4,576 | | | | | | | | | |
Interest income | | 233 | | | 208 | | | | | | | | | |
Interest expense | | (5,422) | | | (3,517) | | | | | | | | | |
| | | | | | | | | | | | |
Other (expense) income, net | | (5,579) | | | 3,811 | | | | | | | | | |
| | | | | | | | | | | | |
(Loss) income from operations, before taxes | | (2,539) | | | 5,078 | | | | | | | | | |
Provision for income taxes | | (1,278) | | | (603) | | | | | | | | | |
| | | | | | | | | | | | |
| | | | | | | | | | | | |
| | | | | | | | | | | | |
| | | | | | | | | | | | |
| | | | | | | | | | | | |
| | | | | | | | | | | | |
Net (loss) income | | (3,817) | | | 4,475 | | | | | | | | | |
Net loss attributable to redeemable non-controlling interests | | — | | | (5) | | | | | | | | | |
Preferred stock dividend | | — | | | (2,129) | | | | | | | | | |
Net (loss) income attributable to Synchronoss | | $ | (3,817) | | | $ | 2,341 | | | | | | | | | |
| | | | | | | | | | | | |
| | | | | | | | | | | | |
| | | | | | | | | | | | |
Earnings (loss) per share: | | | | | | | | | | | | |
| | | | | | | | | | | | |
| | | | | | | | | | | | |
| | | | | | | | | | | | |
Basic | | $ | (0.37) | | | $ | 0.24 | | | | | | | | | |
| | | | | | | | | | | | |
| | | | | | | | | | | | |
| | | | | | | | | | | | |
Diluted | | $ | (0.37) | | | $ | 0.23 | | | | | | | | | |
Weighted average common shares outstanding: | | | | | | | | | | | | |
Basic | | 10,201 | | | 9,842 | | | | | | | | | |
Diluted | | 10,201 | | | 10,277 | | | | | | | | | |
________________________________
1 Cost of revenues excludes depreciation and amortization which are shown separately.
See accompanying notes to condensed consolidated financial statements.
SYNCHRONOSS TECHNOLOGIES, INC.
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)
(Unaudited) (In thousands)
| | | | | | | | | | | | | | | | | | | | | | |
| | Three Months Ended March 31, | | | | |
| | 2025 | | 2024 | | | | | | | | |
Net (loss) income: | | $ | (3,817) | | | $ | 4,475 | | | | | | | | | |
Other comprehensive income (loss), net of tax: | | | | | | | | | | | | |
Foreign currency translation adjustments | | 8,853 | | | (6,109) | | | | | | | | | |
| | | | | | | | | | | | |
| | | | | | | | | | | | |
| | | | | | | | | | | | |
Comprehensive income (loss) | | 5,036 | | | (1,634) | | | | | | | | | |
Comprehensive loss attributable to redeemable non-controlling interests | | — | | | (5) | | | | | | | | | |
Comprehensive income (loss) attributable to Synchronoss | | $ | 5,036 | | | $ | (1,639) | | | | | | | | | |
See accompanying notes to condensed consolidated financial statements.
SYNCHRONOSS TECHNOLOGIES, INC.
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY
(Unaudited) (In thousands)
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Three Months Ended March 31, 2025 |
| Common Stock | | | | | | | | | | |
| Shares | | Par Value | | | | | | Additional Paid-In Capital | | Accumulated Other Comprehensive (Loss) Income | | Accumulated Deficit | | Total Stockholders' Equity |
Balance at December 31, 2024 | 11,075 | | | $ | 1 | | | | | | | $ | 495,906 | | | $ | (41,137) | | | $ | (424,995) | | | $ | 29,775 | |
Stock-based compensation | — | | | — | | | | | | | 1,436 | | | — | | | — | | | 1,436 | |
Issuance of restricted stock | 501 | | | — | | | | | | | — | | | — | | | — | | | — | |
Issuance of common stock on exercise of options | 1 | | | — | | | | | | | 13 | | | — | | | — | | | 13 | |
Shares withheld for taxes in connection with issuance of restricted stock | (79) | | | — | | | | | | | (822) | | | — | | | — | | | (822) | |
Net loss | — | | | — | | | | | | | — | | | — | | | (3,817) | | | (3,817) | |
| | | | | | | | | | | | | | | |
Total other comprehensive income | — | | | — | | | | | | | — | | | 8,853 | | | — | | | 8,853 | |
| | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | |
Balance at March 31, 2025 | 11,498 | | | $ | 1 | | | | | | | $ | 496,533 | | | $ | (32,284) | | | $ | (428,812) | | | $ | 35,438 | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Three Months Ended March 31, 2024 |
| Common Stock | | | | | | | | | | |
| Shares | | Par Value | | | | | | Additional Paid-In Capital | | Accumulated Other Comprehensive (Loss) Income | | Accumulated Deficit | | Total Stockholders' Equity |
Balance at December 31, 2023 | 10,314 | | | $ | 1 | | | | | | | $ | 483,527 | | | $ | (25,732) | | | $ | (431,164) | | | $ | 26,632 | |
Stock-based compensation | — | | | — | | | | | | | 1,089 | | | — | | | — | | | 1,089 | |
| | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | |
Issuance of restricted stock | 1 | | | — | | | | | | | — | | | — | | | — | | | — | |
| | | | | | | | | | | | | | | |
Preferred stock dividend | — | | | — | | | | | | | (2,129) | | | — | | | — | | | (2,129) | |
Net income | — | | | — | | | | | | | — | | | — | | | 4,475 | | | 4,475 | |
Non-controlling interest | — | | | — | | | | | | | 5 | | | — | | | (5) | | | — | |
Total other comprehensive loss | — | | | — | | | | | | | — | | | (6,109) | | | — | | | (6,109) | |
| | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | |
Balance at March 31, 2024 | 10,315 | | | $ | 1 | | | | | | | $ | 482,492 | | | $ | (31,841) | | | $ | (426,694) | | | $ | 23,958 | |
See accompanying notes to condensed consolidated financial statements.
SYNCHRONOSS TECHNOLOGIES, INC.
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(Unaudited) (In thousands)
| | | | | | | | | | | | | | | | |
| | Three Months Ended March 31, |
| | 2025 | | 2024 | | |
Operating activities: | | | | | | |
Net (loss) income from operations | | $ | (3,817) | | | $ | 4,475 | | | |
| | | | | | |
| | | | | | |
| | | | | | |
| | | | | | |
Adjustments to reconcile net (loss) income to net cash from operating activities: | | | | | | |
Depreciation and amortization | | 4,078 | | | 4,359 | | | |
| | | | | | |
| | | | | | |
| | | | | | |
Amortization of debt issuance costs | | 767 | | | 408 | | | |
| | | | | | |
| | | | | | |
| | | | | | |
| | | | | | |
| | | | | | |
| | | | | | |
| | | | | | |
| | | | | | |
| | | | | | |
| | | | | | |
| | | | | | |
| | | | | | |
Deferred income taxes | | (1,668) | | | 7 | | | |
| | | | | | |
Stock-based compensation | | 2,129 | | | 1,110 | | | |
| | | | | | |
| | | | | | |
| | | | | | |
Other, net | | 4,753 | | | (3,931) | | | |
Changes in operating assets and liabilities: | | | | | | |
Accounts receivable, net | | (1,093) | | | 918 | | | |
Prepaid expenses and other current assets | | 120 | | | 1,627 | | | |
Accounts payable | | (3,221) | | | (1,149) | | | |
Accrued expenses | | 1,145 | | | (6,158) | | | |
| | | | | | |
Other assets | | (95) | | | (5) | | | |
Deferred revenues | | (261) | | | (422) | | | |
Other liabilities | | (2,544) | | | (712) | | | |
| | | | | | |
Net cash provided by operating activities | | 293 | | | 527 | | | |
| | | | | | |
Investing activities: | | | | | | |
Purchases of fixed assets | | (324) | | | (517) | | | |
Additions to capitalized software | | (2,986) | | | (3,286) | | | |
| | | | | | |
| | | | | | |
| | | | | | |
| | | | | | |
| | | | | | |
| | | | | | |
| | | | | | |
| | | | | | |
| | | | | | |
| | | | | | |
| | | | | | |
Net cash used in investing activities | | (3,310) | | | (3,803) | | | |
| | | | | | |
Financing activities: | | | | | | |
Share-based compensation-related proceeds | | 13 | | | — | | | |
Taxes paid on withholding shares | | (822) | | | — | | | |
| | | | | | |
| | | | | | |
| | | | | | |
| | | | | | |
| | | | | | |
| | | | | | |
| | | | | | |
| | | | | | |
Repayment of Term Loan | | (469) | | | — | | | |
Drawdown on A/R Facility | | — | | | 3,000 | | | |
Repayment of A/R Facility | | — | | | (3,000) | | | |
| | | | | | |
| | | | | | |
| | | | | | |
| | | | | | |
| | | | | | |
| | | | | | |
Series B Preferred dividend paid in the form of cash | | — | | | (2,129) | | | |
| | | | | | |
| | | | | | |
| | | | | | |
Net cash used in financing activities | | (1,278) | | | (2,129) | | | |
| | | | | | |
Effect of exchange rate changes on cash | | 58 | | | (67) | | | |
| | | | | | |
Net decrease in cash and cash equivalents | | (4,237) | | | (5,472) | | | |
| | | | | | |
| | | | | | |
Beginning cash and cash equivalents | | 33,375 | | | 24,572 | | | |
| | | | | | |
| | | | | | |
Ending cash and cash equivalents | | $ | 29,138 | | | $ | 19,100 | | | |
| | | | | | |
| | | | | | |
| | | | | | |
| | | | | | |
| | | | | | |
See accompanying notes to condensed consolidated financial statements.
SYNCHRONOSS TECHNOLOGIES, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS — UNAUDITED
(Amounts in tables in thousands, except for per share data or unless otherwise noted)
Note 1. Description of Business
General
Synchronoss Technologies, Inc. (“Synchronoss” or the “Company”) is a leading provider of white label cloud software and services that enable our customers to keep subscribers, systems, networks, and content in sync.
The Synchronoss Personal CloudTM platform is a secure and highly scalable white label platform that allows our customers’ subscribers to backup and protect, engage with, and manage their personal content and gives our operator customers the ability to increase average revenue per user (“ARPU”) and reduce churn.
Designed for smartphones, tablets, and desktops across all operating systems, our platform ensures a seamless cross-device experience.
Note 2. Basis of Presentation and Consolidation
The accompanying interim unaudited condensed consolidated financial statements have been prepared by Synchronoss and, in the opinion of management, include all adjustments necessary for a fair presentation of the Company’s financial position, results of operations, and cash flows for the interim periods. They do not include all of the information and footnotes required by U.S. generally accepted accounting principles (“GAAP”) for complete financial statements and should be read in conjunction with the Company’s audited consolidated financial statements and related notes included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2024. The results of operations for the three months ended March 31, 2025 are not necessarily indicative of the results to be expected for the year ending December 31, 2025.
The condensed consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries. All material intercompany transactions and accounts are eliminated in consolidation.
Unless otherwise noted, tables are presented in U.S. dollars in thousands. Certain columns and rows may not add due to the use of rounded numbers. Percentages and Earnings per share (“EPS”) amounts presented are calculated from the underlying numbers in thousands. We may reclassify certain prior year amounts to conform with current year presentation.
For further information about the Company’s basis of presentation and consolidation or its significant accounting policies, refer to the consolidated financial statements and footnotes thereto included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2024.
Recently Issued Accounting Standards
Standards recently adopted
| | | | | | | | | | | | | | |
Standard | | Description | | Effect on the financial statements |
Update 2024-01 - Compensation—Stock Compensation (Topic 718) - Scope Application of Profits Interest and Similar Awards | | The amendments in this Update related to the scope application issue apply to all reporting entities that account for profits interest awards as compensation to employees or nonemployees in return for goods or services. This Update provides specific examples to help stakeholders to determine whether a profits interest award should be accounted for as a share-based payment arrangement (Topic 718) or similar to a cash bonus or profit-sharing arrangement (Topic 710, Compensation—General, or other Topics). | | The Company evaluated these changes and noted that the adoption of this standard did not have a material impact on the Company’s consolidated financial position or results of operations. |
Date of adoption: January 1, 2025 | | | | |
SYNCHRONOSS TECHNOLOGIES, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS — UNAUDITED
(Amounts in tables in thousands, except for per share data or unless otherwise noted)
Standards issued not yet adopted
| | | | | | | | | | | | | | |
Standard | | Description | | Effect on the financial statements |
Update 2024-03 - Income Statement—Reporting Comprehensive Income—Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses | | Requires a public business entity to disclose, on an annual basis and interim basis, disaggregated information about certain income statement line items in a tabular format in the notes to the financial statements. The guidance does not change what is presented on the face of the income statement. | | The Company continues to evaluate these changes and does not anticipate any material impact on the Company’s consolidated financial position or results of operations upon adoption. |
Planned date of adoption: January 1, 2027 | | | | |
Update 2023-09 - Income Taxes (Topic 740) - Improvements to Income Tax Disclosures | | The amendments in this Update related to the rate reconciliation and income taxes paid disclosures improve the transparency of income tax disclosures by requiring (1) consistent categories and greater disaggregation of information in the rate reconciliation and (2) income taxes paid disaggregated by jurisdiction. | | The Company evaluated these changes and noted that the adoption of this standard did not have a material impact on the Company’s consolidated financial position or results of operations. The ASU is effective for annual periods beginning after December 15, 2024, and will not impact interim disclosures for 2025. |
Planned date of adoption: December 31, 2025 | | | | |
Note 3. Revenue
Disaggregation of Revenue
The Company disaggregates revenue from contracts with customers into the nature of the services and geographical regions. The Company’s geographic regions are the North America, Europe, the Middle East and Africa (“EMEA”), and Asia Pacific (“APAC”). The majority of the Company’s revenue is from the technology, media, and telecom (“TMT”) sector.
| | | | | | | | | | | |
| Three Months Ended March 31, |
| 2025 | | 2024 |
Geography: | | | |
North America | $ | 40,355 | | | $ | 39,641 | |
APAC | 1,506 | | | 1,548 | |
EMEA | 352 | | | 1,776 | |
Total revenue | $ | 42,213 | | | $ | 42,965 | |
| | | |
Service Line: | | | |
Professional Services | $ | 2,727 | | | $ | 3,773 | |
| | | |
Subscription Services | 39,292 | | | 39,143 | |
License | 194 | | | 49 | |
Total revenue | $ | 42,213 | | | $ | 42,965 | |
Trade Accounts Receivable and Contract Balances
The Company classifies its right to consideration in exchange for deliverables as either a receivable or a contract asset. A
SYNCHRONOSS TECHNOLOGIES, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS — UNAUDITED
(Amounts in tables in thousands, except for per share data or unless otherwise noted)
receivable is a right to consideration that is unconditional (i.e., only the passage of time is required before payment is due). For example, the Company recognizes a receivable for revenues related to its time and materials and volume-based contracts. The Company presents such receivables in Trade accounts receivable, net on the Condensed Consolidated Balance Sheets at their net estimated realizable value. The Company maintains an allowance for credit losses to provide for the estimated amount of receivables that may not be collected. The allowance is based upon an assessment of customer creditworthiness, historical payment experience, the age of outstanding receivables, and other applicable factors.
A contract asset is a right to consideration that is conditional upon factors other than the passage of time. For example, the Company would record a contract asset if it records revenue on a professional services engagement but are not entitled to bill until the Company achieves specified milestones. The Company presents such contract assets in Other current assets and Other noncurrent assets on the Condensed Consolidated Balance Sheets. The contract asset balance was $0.5 million and $0.6 million at March 31, 2025 and December 31, 2024, respectively.
Amounts collected in advance of services being provided are accounted for as contract liabilities, which are presented as Deferred revenue, current on the Condensed Consolidated Balance Sheets and are realized with the associated revenue recognized under the contract. Nearly all of the Company's contract liabilities balance are related to services revenue, primarily subscription services contracts.
The Company’s contract assets and liabilities are reported in a net position on a customer basis at the end of each reporting period.
Significant changes in the contract liabilities balance during the period are as follows:
| | | | | | |
| | Contract Liabilities1 |
Balance at December 31, 2024 | | $ | 837 | |
Revenue recognized in the period | | (42,264) | |
Amounts billed but not initially recognized as revenue | | 42,027 | |
| | |
| | |
Balance at March 31, 2025 | | $ | 600 | |
________________________________
1 Comprised of Deferred Revenue. $0.3 million of revenue recognized in the period was included in the contract liability balance at the beginning of the period.
Transaction Price Allocated to the Remaining Performance Obligations
Topic 606 requires that the Company disclose the aggregate amount of transaction price that is allocated to performance obligations that have not yet been satisfied as of March 31, 2025. The Company has elected not to disclose transaction price allocated to remaining performance obligations for:
1.Contracts with an original duration of one year or less, including contracts that can be terminated for convenience without a substantive penalty.
2.Contracts for which the Company recognizes revenues based on the right to invoice for services performed.
3.Variable consideration allocated entirely to a wholly unsatisfied performance obligation or to a wholly unsatisfied promise to transfer a distinct good or service that forms part of a single performance obligation in accordance with Topic 606 Section 10-25-14(b), for which the criteria in Topic 606 Section 10-32-40 have been met. This applies to a limited number of situations where the Company is dependent upon data from a third party or where fees are highly variable.
Many of the Company’s performance obligations meet one or more of these exemptions. Specifically, the Company has excluded the following from the Company’s remaining performance obligations, all of which will be resolved in the period in which amounts are known:
•consideration for future transactions, above any contractual minimums
SYNCHRONOSS TECHNOLOGIES, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS — UNAUDITED
(Amounts in tables in thousands, except for per share data or unless otherwise noted)
•consideration for success-based transactions contingent on third party data
•credits for failure to meet future service level requirements
As of March 31, 2025, the aggregate amount of transaction price allocated to remaining performance obligations, other than those meeting the exclusion criteria above, was $149.3 million, of which approximately 88.8% is expected to be recognized as revenues within 2 years, and the remainder thereafter.
Estimates of revenue expected to be recognized in future periods also exclude unexercised customer options to purchase services that do not represent material rights to the customer. Customer options that do not represent a material right are only accounted for in accordance with Topic 606 when the customer exercises its option to purchase additional goods or services.
Note 4. Segment Information
The Company assessed its current structure and operations and determined it has one operating segment and a single reportable segment as the business is managed and assessed by the chief operating decision-maker based on the consolidated results of the organization. The Chief Executive Officer is the chief operating decision-maker (“CODM”) for the Company.
The segment derives revenues from customers through the Company’s cloud product under software-as-a-service arrangements.
The accounting policies of the single segment are the same as those described in the summary of significant accounting policies. The CODM assesses performance and decides how to allocate resources based on consolidated net income (loss) from continuing operations. The measure of segment assets is reported on the balance sheet as total consolidated assets.
The CODM uses consolidated net income (loss) from continuing operations to evaluate the overall financial performance of the company. The focus is on revenue performance as well as on comparing actual functional spend categories to forecast and, occasionally, prior-year results to assess variances and trends. Decisions regarding resource allocation are primarily made during the annual budget planning process and augmented as needed throughout the year.
SYNCHRONOSS TECHNOLOGIES, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS — UNAUDITED
(Amounts in tables in thousands, except for per share data or unless otherwise noted)
Segment operating results and a reconciliation of segment operating income to consolidated net income (loss) from continuing operations are as follows:
| | | | | | | | | | | | | | | | | | |
| | | | Three Months Ended March 31, |
| | | | | | 2025 | | 2024 | | |
| | | | | | | | | | |
| | | | | | | | | | |
Net revenues1 | | | | | | $ | 42,213 | | | $ | 42,965 | | | |
Less (add): | | | | | | | | | | |
Employees related expense net of capitalized software | | | | | | 18,834 | | | 19,826 | | | |
Hosting expense | | | | | | 3,732 | | | 3,946 | | | |
Professional services expense | | | | | | 4,413 | | | 5,304 | | | |
Other segment items2 | | | | | | 8,506 | | | 1,143 | | | |
Depreciation and amortization | | | | | | 4,078 | | | 4,359 | | | |
| | | | | | | | | | |
| | | | | | | | | | |
Interest income | | | | | | (233) | | | (208) | | | |
Interest expense | | | | | | 5,422 | | | 3,517 | | | |
| | | | | | | | | | |
| | | | | | | | | | |
| | | | | | | | | | |
| | | | | | | | | | |
Provision (benefit) for income taxes | | | | | | 1,278 | | | 603 | | | |
Segment net (loss) income | | | | | | (3,817) | | | 4,475 | | | |
Reconciliation of profit or loss | | | | | | | | | | |
Adjustments and reconciling items | | | | | | — | | | — | | | |
| | | | | | | | | | |
Consolidated net (loss) income from continuing operations | | | | | | $ | (3,817) | | | $ | 4,475 | | | |
_____________________________1 There are no intra-entity sales or transfers.
2 Other segment items include: administrative expense, facilities expense, maintenance charges, restructuring expense, sales and marketing expense, stock-based compensation expense, non-cash impact of the foreign exchange gains and losses on intercompany payables and receivables, and other overhead expense.
Note 5. Accounts Receivable Securitization Facility
On June 23, 2022 (the “A/R Closing Date”), the Company and certain of its subsidiaries (together with the Company, the “Company Group”) entered into a $15 million accounts receivable securitization facility (the “A/R Facility”) with Norddeutsche Landesbank Girozentrale.
The A/R Facility transaction includes (i) Receivables Purchase Agreements (the “Receivables Purchase Agreements”) dated as of the Closing Date, among the Company, as initial servicer, SN Technologies, LLC, a wholly owned special purpose subsidiary of the Company (“SN Technologies”), as seller, Norddeutsche Landesbank Girozentrale, as administrative agent (the “Administrative Agent”), and the purchasers party thereto, the group agents party thereto and the originators party thereto; (ii) Purchase and Sale Agreements (the “Purchase and Sale Agreements”) dated as of the Closing Date, between the Company Group, as originators (the “Originators”), and SN Technologies, as purchaser; (iii) the Administration Agreement (the “Administration Agreement”) dated as of the Closing Date, between the Company, as servicer, and Finacity Corporation, as administrator; and (iv) the Performance Guaranty (the “Performance Guaranty”) dated as of the Closing Date made by the Company in favor of the Administrative Agent.
Pursuant to the Purchase and Sale Agreements, the Originators will sell existing and future accounts receivable (and related assets) (the “Receivables”) to SN Technologies in exchange for cash and/or subordinated notes. The Originators and SN Technologies intend the transactions contemplated by the Purchase and Sale Agreements to be true sales to SN Technologies by the respective Originators. Pursuant to the Receivables Purchase Agreement, SN Technologies will in turn grant an undivided security interest to the Administrative Agent in the Receivables in exchange for a credit facility permitting borrowings of up to $15 million outstanding from time to time. Yield is payable to the Administrative Agent under the Receivables Purchase Agreements at a variable rate based on the Norddeutsche Landesbank Girozentrale’s Hanover funding rate plus a 2.35% margin. The Company’s commitment fee shall equal 0.85% per annum on the average daily unused outstanding capital. Pursuant to the Performance Guaranty, the Company guarantees the performance of the Originators of their obligations under the Purchase and Sale Agreements.
SYNCHRONOSS TECHNOLOGIES, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS — UNAUDITED
(Amounts in tables in thousands, except for per share data or unless otherwise noted)
The Company has not agreed to guarantee any obligations of SN Technologies or the collection of any of the receivables and will not be responsible for any obligations to the extent the failure to perform such obligations by the Company or any Originators results from receivables being uncollectible on account of the insolvency, bankruptcy or lack of creditworthiness or other financial inability to pay of the related obligor.
Unless earlier terminated or subsequently extended pursuant to the terms of the Receivables Purchase Agreement, the A/R Facility will expire on June 23, 2025.
The Company did not draw on the A/R Facility for the three months ended March 31, 2025. The Company drew $3.0 million on the A/R Facility for the three months ended March 31, 2024, and had repaid the balance in full as of March 31, 2024. The interest associated with the draw and repayment was not material for the prior period. The drawdown and subsequent repayment of the A/R Facility represent financing activities, as reported on the Condensed Consolidated Statements of Cash Flows. As of March 31, 2025 approximately $2.3 million of the Company’s receivables are held by SN Technologies. As of March 31, 2025 there were no outstanding borrowings against the A/R facility and $1.3 million was available for the Company to draw under the A/R Facility.
The Company drew $3.0 million on the A/R Facility on April 21, 2025 and had not repaid the balance as of the day of filing this quarterly Form 10-Q.
Note 6. Fair Value Measurements
In accordance with US GAAP, fair value is defined as the price that would be received to sell an asset, or paid to transfer a liability in an orderly transaction between market participants at the measurement date. A three-level hierarchy prioritizes the inputs used to measure fair value as follows:
•Level 1 - Observable inputs - quoted prices in active markets for identical assets and liabilities.
•Level 2 - Observable inputs other than the quoted prices in active markets for identical assets and liabilities includes quoted prices for similar instruments, quoted prices for identical or similar instruments in inactive markets, and amounts derived from valuation models where all significant inputs are observable in active markets.
•Level 3 - Unobservable inputs - includes amounts derived from valuation models where one or more significant inputs are unobservable and require the Company to develop relevant assumptions.
SYNCHRONOSS TECHNOLOGIES, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS — UNAUDITED
(Amounts in tables in thousands, except for per share data or unless otherwise noted)
The following is a summary of assets and liabilities, and their related classifications under the fair value hierarchy:
| | | | | | | | | | | | | | | | | | | | | | | |
| March 31, 2025 |
| Total | | (Level 1) | | (Level 2) | | (Level 3) |
Assets | | | | | | | |
Money market accounts1 | $ | 12,110 | | | $ | 12,110 | | | $ | — | | | $ | — | |
| | | | | | | |
| | | | | | | |
Total assets | $ | 12,110 | | | $ | 12,110 | | | $ | — | | | $ | — | |
Liabilities | | | | | | | |
Performance-based cash units2,3 | $ | 1,643 | | | $ | — | | | $ | 1,643 | | | $ | — | |
| | | | | | | |
Total liabilities | $ | 1,643 | | | $ | — | | | $ | 1,643 | | | $ | — | |
| | | | | | | |
| | | | | | | |
| | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | |
| December 31, 2024 |
| Total | | (Level 1) | | (Level 2) | | (Level 3) |
Assets | | | | | | | |
Money market accounts1 | $ | 9,552 | | | $ | 9,552 | | | $ | — | | | $ | — | |
| | | | | | | |
| | | | | | | |
Total assets | $ | 9,552 | | | $ | 9,552 | | | $ | — | | | $ | — | |
Liabilities | | | | | | | |
Performance-based cash units2,3 | $ | 948 | | | $ | — | | | $ | 948 | | | $ | — | |
| | | | | | | |
Total liabilities | $ | 948 | | | $ | — | | | $ | 948 | | | $ | — | |
| | | | | | | |
| | | | | | | |
| | | | | | | |
________________________________
1 Included in Cash and cash equivalents on the Condensed Consolidated Balance Sheets.
2 The short term portion is included in Accrued expenses and the long-term portion is included in Other liabilities, non-current on the Condensed Consolidated Balance Sheets.
3 For a discussion of performance-based cash units see Note 12. Stock Plans of the Notes to Condensed Consolidated Financial Statements in Item 1 of this Form 10-Q.
Refer to Note 9. Debt of the Notes to Condensed Consolidated Financial Statements in Item 1 of this Form 10-Q for presentation of Fair Value of Debt.
Note 7. Note Receivable
Sequential Technology International, LLC
During the second quarter of 2020, the Company entered into an agreement with Sequential Technology International, LLC (“STIN”) and AP Capital Holdings II, LLC (“APC”) to divest its remaining equity interest in STIN as well as settle its paid-in-kind purchase money note (“PIK note”) and certain amounts due as of December 31, 2019 in consideration for a $9.0 million secured promissory note (the “Note”). As of December 31, 2022, the carrying value of the Note after the consideration of the allowance for credit loss was approximately $4.8 million. The Company determined the allowance on the Note using a discounted cash flow analysis, which discounts the expected future cash flows of the asset to determine the collectible amount.
During the third quarter of 2023, the interest payment for the Note was not received by the Company from STIN. In the third quarter of 2023 the Company reassessed the collectability of the Note and determined that a full allowance for credit losses was required equal to the carrying value of the Note, recorded within the Selling, general and administrative expenses line item on the Consolidated Statements of Operations.
During the first quarter of 2024, the Company entered into an agreement with STIN and APC to amend the aforementioned promissory note and reduce the principal balance to $3.0 million, forgive outstanding accrued interest and extend the maturity date of the Note to September 2027.
On January 8, 2025, the Company and STIN, APC and Sequential Technology International Holdings, LLC (collectively the “Sequential Parties”) entered into an Amended and Restated Settlement Agreement (“Settlement Agreement”) to further amend the amounts due from STIN under the Note in connection with a transaction through which the Sequential Parties were
SYNCHRONOSS TECHNOLOGIES, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS — UNAUDITED
(Amounts in tables in thousands, except for per share data or unless otherwise noted)
acquired. Under the Settlement Agreement the Company received $1.6 million in past-due rent and contingent consideration which the Company may be entitled to if certain key performance indicators are met within the time periods specified in that Agreement. Given the full allowance for credit losses had been recorded against the Note in 2023, the modification of the terms of the Note had no net impact on the consolidated financial statements for the year ended March 31, 2025.
Note 8. Leases
The Company has entered into contracts with third parties to lease a variety of assets, including certain real estate, equipment, automobiles, and other assets. The Company’s leases frequently allow for lease payments that could vary based on factors such as inflation or the degree of utilization of the underlying asset. For example, certain of the Company’s real estate leases could require us to make payments that vary based on common area maintenance charges, insurance, and other charges. The Company’s lease agreements do not contain any material residual value guarantees or material restrictive covenants.
The Company is party to certain sublease arrangements, primarily related to the Company’s real estate leases, where it acts as the lessee and intermediate lessor.
Assets under operating leases are included in Operating lease right-of-use assets, with the related short-term liabilities included in Accrued expenses and long-term portion included in Leases, non-current on the Condensed Consolidated Balance Sheets.
Assets under finance leases are included in Property, plant and equipment, net, with the related short-term liabilities included in Accrued expenses and long-term portion in Leases, non-current on the Condensed Consolidated Balance Sheets.
Operating lease costs are recognized on a straight-line basis over the lease terms. Finance lease assets are amortized on a straight-line basis over the shorter of the estimated useful lives of the assets or the lease terms.
The following table presents information about the Company's right-of-use (“ROU”) assets and lease liabilities:
| | | | | | | | | | | | | | |
| | March 31, 2025 | | December 31, 2024 |
Operating lease assets: | | | | |
Non-current operating lease ROU assets | | $ | 7,900 | | | $ | 8,445 | |
Finance lease assets: | | | | |
Equipment, net | | 1,370 | | | 1,137 | |
| | | | |
| | | | |
| | | | |
Operating lease liabilities: | | | | |
Lease liabilities, current | | 6,179 | | | 6,010 | |
Lease liabilities, non-current | | 14,791 | | | 16,320 | |
Total operating lease liabilities | | $ | 20,970 | | | $ | 22,330 | |
| | | | |
Finance lease liabilities: | | | | |
Lease liabilities, current | | 838 | | | 722 | |
Lease liabilities, non-current | | 603 | | | 456 | |
Total finance lease liabilities | | $ | 1,441 | | | $ | 1,178 | |
SYNCHRONOSS TECHNOLOGIES, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS — UNAUDITED
(Amounts in tables in thousands, except for per share data or unless otherwise noted)
The following table presents information about lease expense and sublease income:
| | | | | | | | | | | | | | | | | |
| Three Months Ended March 31, | | | | |
| 2025 | | 2024 | | | | | | |
Finance leases: | | | | | | | | | |
Interest expense | $ | 31 | | | $ | 28 | | | | | | | |
Depreciation expense | 186 | | | 167 | | | | | | | |
Total finance leases | $ | 217 | | | $ | 195 | | | | | | | |
| | | | | | | | | |
Operating leases: | | | | | | | | | |
Operating lease cost1 | $ | 1,033 | | | $ | 1,424 | | | | | | | |
Other lease costs and income: | | | | | | | | | |
Variable lease costs1 | 363 | | | 141 | | | | | | | |
| | | | | | | | | |
Sublease income1,2 | (2,452) | | | (1,019) | | | | | | | |
Total operating leases | (1,056) | | | 546 | | | | | | | |
Total net lease cost | $ | (839) | | | $ | 741 | | | | | | | |
| | | | | | | | | |
________________________________
1 Amounts are included in Cost of revenues, Selling, general and administrative and/or Research and development based on the function that the underlying leased asset supports, which are reflected on the Condensed Consolidated Statements of Operations.
2 Amounts include receipt of a $1.6 million past due sublease payment in the current period, for which we previously recorded an allowance for credit losses.
The following table provides the undiscounted amount of future cash flows included in the Company’s lease liabilities at March 31, 2025 for each of the five years subsequent to December 31, 2024 and thereafter, as well as a reconciliation of such undiscounted cash flows to our lease liabilities at March 31, 2025:
| | | | | | | | | | | | | | |
| | Operating Leases | | Finance Leases |
2025 | | $ | 5,683 | | | $ | 733 | |
2026 | | 7,577 | | | 661 | |
2027 | | 6,216 | | | 144 | |
2028 | | 4,276 | | | — | |
2029 | | — | | | — | |
| | | | |
Total future lease payments | | 23,752 | | | 1,538 | |
Less: amount representing interest | | (2,782) | | | (97) | |
Present value of future lease payments (lease liability) | | $ | 20,970 | | | $ | 1,441 | |
SYNCHRONOSS TECHNOLOGIES, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS — UNAUDITED
(Amounts in tables in thousands, except for per share data or unless otherwise noted)
The following table provides the weighted average remaining lease term and weighted-average discount rates for our leases:
| | | | | | | | | | | |
| March 31, 2025 | | December 31, 2024 |
Weighted average remaining lease term (years), weighted based on lease liability balances: | | | |
Finance leases | 2.1 | | 2.0 |
Operating leases | 3.3 | | 3.7 |
| | | |
Weighted average discount rate (percentages), weighted based on the remaining balance of lease payments: | | | |
Finance leases | 10.2% | | 10.0% |
Operating leases | 8.0% | | 8.0% |
| | | |
The following table provides certain cash flow and supplemental noncash information related to our lease liabilities:
| | | | | | | | | | | | | | | |
| Three Months Ended March 31, | | |
| 2025 | | 2024 | | | | |
Cash paid for amounts included in the measurement of lease liabilities: | | | | | | | |
Finance leases | $ | 190 | | | $ | 186 | | | | | |
Operating leases | 1,886 | | | 1,961 | | | | | |
| | | | | | | |
Lease liabilities arising from obtaining right-of-use assets: | | | | | | | |
Finance leases | $ | 397 | | | $ | 105 | | | | | |
Operating leases | — | | | — | | | | | |
Note 9. Debt
2024 Term Loan
On June 28, 2024 (the “Effective Date”), the Company entered into a Credit Agreement (the “Credit Agreement”) with BGC Lender Rep LLC, as administrative agent, and the lenders party thereto. The Credit Agreement established a senior secured term loan facility of up to $75.0 million (the “Term Loan”), all of which was funded on the Effective Date. The proceeds of the Term Loan were used to (i) fund the Senior Note Repurchase (as defined below), (ii) to fund the Series B Repurchase (as defined below) and (iii) to pay transaction fees and expenses associated with the closing of the transactions contemplated by the Credit Agreement.
The Term Loan matures on June 28, 2028 (the “Maturity Date”); provided that if (i) the Company’s 8.375% Senior Notes due 2026 (the “Senior Notes”) are not refinanced, redeemed or repaid in full prior to March 31, 2026, the Maturity Date shall be March 31, 2026 and (ii) in the event of a refinancing, redemption or repayment of the Senior Notes in full prior to March 31, 2026, the Maturity Date shall be the earlier of (A) June 28, 2028 and (B) the date that is twelve (12) months prior to the final stated maturity date for the indebtedness resulting from such refinancing, redemption or repayment of the Senior Notes in full.
The Term Loan bears interest at a rate per annum equal to the Adjusted Term Secured Overnight Financing Rate (“SOFR”) (as defined in the Credit Agreement) for the applicable interest period, plus 5.50%, subject to a floor of 2.50%.
The Credit Agreement requires the Company to repay the outstanding principal amounts of the Term Loan in an amount of $468,750 on the last day of each fiscal quarter beginning on September 30, 2024 and ending on June 30, 2026. Starting on September 30, 2026, and on the last day of each fiscal quarter thereafter, such repayments of outstanding principal shall be $1,875,000. The final principal repayment of the Term Loan shall be repaid on the Maturity Date in an amount equal to the aggregate principal amount of the Term Loan outstanding on such date. The Company may at any time voluntarily prepay the
SYNCHRONOSS TECHNOLOGIES, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS — UNAUDITED
(Amounts in tables in thousands, except for per share data or unless otherwise noted)
Term Loan, in whole or in part subject to a variable prepayment fee if such prepayment is made prior to the third anniversary of the Effective Date. The Company is required to pay an exit fee of $1.5 million if, among other things, the Maturity Date is extended beyond March 31, 2026. The Credit Agreement also contains mandatory prepayment provisions that are customary for secured financings of this type from excess cash flow and with the proceeds of certain asset sales, tax refunds, equity sales or issuances, and debt issuances, each as more fully described in the Credit Agreement.
The Company made $0.5 million of principal payments on the Term Loan for the three months ending March 31, 2025 in line with the terms of the Credit Agreement.
The Company’s obligations under the Credit Agreement are secured by substantially all of the assets (other than existing real property) of Synchronoss. Other than an Irish Subsidiary (as defined in the Credit Agreement), none of the Company’s direct or indirect foreign subsidiaries or immaterial subsidiaries has guaranteed the loans under the Credit Agreement, but under certain circumstances, such subsidiaries may become guarantors. The Credit Agreement contains customary covenants that limit the Company’s ability and its restricted subsidiaries to, among other things, (i) incur additional indebtedness, (ii) pay dividends or make certain other restricted payments, (iii) sell assets, (iv) make certain investments, (v) grant liens and (vi) enter into transactions with affiliates. These covenants are subject to exceptions and qualifications set forth in the Credit Agreement. The financial covenants set forth in the Credit Agreement include (i) a maximum consolidated secured leverage ratio, which will be tested at the end of each of the Company’s fiscal quarter and (ii) an average liquidity requirement for any calendar month. All borrowings under the Credit Agreement are subject to the satisfaction of customary conditions, including the absence of a default and the accuracy of representations and warranties subject to certain exceptions. Upon the occurrence and continuance of an event of default, which, for example, could be triggered by a breach or violation of, or default under, certain material contracts of the Company, BGC Lender Rep may take either or both of the following actions: (i) terminate the commitments and (ii) declare all outstanding obligations immediately due and payable and take such other actions as set forth in the Credit Agreement.
The Company was in compliance with its debt covenants pertaining to the Term Loan as of March 31, 2025.
2024 Repurchase of Senior Notes and Series B Preferred
On June 28, 2024, the Company used $66.5 million of the proceeds from the Term Loan and $2.6 million non-interest-bearing deferred consideration, which was paid to BRPI in December of 2024, for a total consideration of $69.1 million (“the total consideration”) to repurchase 100% of its outstanding Series B Perpetual Non-Convertible Preferred Stock (the “Series B Preferred”) and 787,590 (14%) of its outstanding Senior Notes from BRPI, a related party.
2021 Senior Notes
On June 30, 2021, the Company closed its underwritten public offering of $120.0 million aggregate principal amount of 8.375% senior notes due 2026 at a par value of $25.00 per senior note (the “Senior Notes”). The offering was conducted pursuant to an underwriting agreement (the “Notes Underwriting Agreement”) dated June 25, 2021, by and among the Company and B. Riley Securities, Inc., as representative of the several underwriters (the “Notes Underwriters”). At the closing, the Company issued $125.0 million aggregate principal amount of Senior Notes, inclusive of $5.0 million aggregate principal amount of Senior Notes issued pursuant to the full exercise of the Notes Underwriters’ option to purchase additional Senior Notes.
The Notes Underwriting Agreement contains customary representations, warranties and covenants of the Company, customary conditions to closing, indemnification obligations of the Company and the Notes Underwriters, including for liabilities under the Securities Act, other obligations of the parties and termination provisions.
On June 30, 2021, the Company entered into an indenture (the “Base Indenture”) and a supplemental indenture (the “First Supplemental Indenture” and, together with the Base Indenture, the “Indenture”) with The Bank of New York Mellon Trust Company National Association, as trustee (the “Trustee”), between the Company and the Trustee. The Indenture establishes the form and provides for the issuance of the Senior Notes.
SYNCHRONOSS TECHNOLOGIES, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS — UNAUDITED
(Amounts in tables in thousands, except for per share data or unless otherwise noted)
The Senior Notes are senior unsecured obligations of the Company and rank equally in right of payment with all of the Company’s existing and future senior unsecured and unsubordinated indebtedness. The Senior Notes are effectively subordinated in right of payment to all of the Company’s existing and future secured indebtedness to the extent of the value of the assets securing such indebtedness and structurally subordinated to all existing and future indebtedness of the Company’s subsidiaries, including trade payables. The Senior Notes bear interest at the rate of 8.375% per annum. Interest on the Senior Notes is payable quarterly in arrears on January 31, April 30, July 31 and October 31 of each year, commencing on July 31, 2021. The Senior Notes will mature on June 30, 2026, unless redeemed prior to maturity.
The Company may, at its option, at any time and from time to time, redeem the Senior Notes for cash in whole or in part (i) on or after June 30, 2022 and prior to June 30, 2023, at a price equal to $25.75 per Senior Note, plus accrued and unpaid interest to, but excluding, the date of redemption, (ii) on or after June 30, 2023 and prior to June 30, 2024, at a price equal to $25.50 per Senior Note, plus accrued and unpaid interest to, but excluding, the date of redemption, (iii) on or after June 30, 2024 and prior to June 30, 2025, at a price equal to $25.25 per Senior Note, plus accrued and unpaid interest to, but excluding, the date of redemption, and (iv) on or after June 30, 2025 and prior to maturity, at a price equal to 100% of their principal amount, plus accrued and unpaid interest to, but excluding, the date of redemption. On and after any redemption date, interest will cease to accrue on the redeemed Senior Notes.
The Indenture contains customary events of default and cure provisions. If an uncured default occurs and is continuing, the Trustee or the holders of at least 25% of the principal amount of the Senior Notes may declare the entire amount of the Senior Notes, together with accrued and unpaid interest, if any, to be immediately due and payable. In the case of an event of default involving the Company’s bankruptcy, insolvency or reorganization, the principal of, and accrued and unpaid interest on, the principal amount of the Senior Notes, together with accrued and unpaid interest, if any, will automatically, and without any declaration or other action on the part of the Trustee or the holders of the Senior Notes, become due and payable.
On October 25, 2021, the Company entered into an At Market Issuance Sales Agreement (the “Sales Agreement”) between the Company and B. Riley Securities, Inc. (the “Agent”), a related party, pursuant to which the Company may offer and sell, from time to time, up to $18.0 million of the Company’s 8.375% Senior Notes due 2026. Sales of the additional Senior Notes pursuant to the Sales Agreement, if any, may be made in transactions that are deemed to be “at the market offerings” as defined in Rule 415 under the Securities Act of 1933, as amended (the “Securities Act”). Under the Sales Agreement, the Agent will be entitled to compensation of 2.0% of the gross proceeds of all notes sold through it as the Company’s agent.
During the fourth quarter of 2021, the Company sold an additional $16.1 million aggregate principal amount of Senior Notes pursuant to the Sales Agreement. The additional Senior Notes sold have terms identical to the initial Senior Notes and are fungible and vote together with, the initial Senior Notes. The Senior Notes are listed and trade on The Nasdaq Global Market under the symbol “SNCRL.”
On June 28, 2024, Synchronoss repurchased 787,590 of its Senior Notes from BRPI, as described above.
The Company was in compliance with its debt covenants pertaining to the Senior Notes as of March 31, 2025.
On April 24, 2025 the Company entered into an agreement with TP Birch Grove to refinance its existing 2021 Senior Notes and 2024 Term Loan facilities with a new $200 million, four-year Term Loan. Refer to Note 19. Subsequent Events of the Notes to Condensed Consolidated Financial Statements in Item 1 of this Form 10-Q for further detail on the transaction.
SYNCHRONOSS TECHNOLOGIES, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS — UNAUDITED
(Amounts in tables in thousands, except for per share data or unless otherwise noted)
Carrying Value of Debt
The carrying amounts of the Company’s borrowings were as follows:
| | | | | | | | | | | | | | |
| | March 31, 2025 | | December 31, 2024 |
2021 Senior Notes: | | | | |
Senior Notes | | $ | 121,387 | | | $ | 121,387 | |
Unamortized discount and debt issuance cost1 | | (2,214) | | | (2,625) | |
Carrying value of Senior Notes | | 119,173 | | | 118,762 | |
2024 Term Loan: | | | | |
Term Loan | | 73,594 | | | 74,063 | |
Unamortized debt issuance cost1 | | (5,726) | | | (6,110) | |
| | | | |
Carrying value of Term Loan | | 67,868 | | | 67,953 | |
Total carrying value of debt | | 187,041 | | | 186,715 | |
Current portion of long-term debt | | 1,875 | | | 1,875 | |
Long-term debt, net of current portion | | $ | 185,166 | | | $ | 184,840 | |
________________________________
1 Debt issuance costs are deferred and amortized into interest expense using the effective interest method.
Fair Value of Debt
The fair value of the 2021 Senior Notes was determined based on the closing trading price of the Senior Notes as of March 31, 2025 and is categorized accordingly as Level 2 in the fair value hierarchy. The fair value of the 2024 Term Loan was obtained using the Discounted Cash Flow (“DCF”) valuation model with observable inputs as of March 31, 2025 and is categorized accordingly as Level 2 in the fair value hierarchy.
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | Balance at March 31, 2025 |
| | | | Fair Value |
| | Carrying Amount | | (Level 1) | | (Level 2) | | (Level 3) | | Total |
| | | | | | | | | | |
| | | | | | | | | | |
| | | | | | | | | | |
Total debt | | $ | 187,041 | | | $ | — | | | $ | 188,683 | | | $ | — | | | $ | 188,683 | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | Balance at December 31, 2024 |
| | | | Fair Value |
| | Carrying Amount | | (Level 1) | | (Level 2) | | (Level 3) | | Total |
| | | | | | | | | | |
| | | | | | | | | | |
| | | | | | | | | | |
Total debt | | $ | 186,715 | | | $ | — | | | $ | 193,275 | | | $ | — | | | $ | 193,275 | |
SYNCHRONOSS TECHNOLOGIES, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS — UNAUDITED
(Amounts in tables in thousands, except for per share data or unless otherwise noted)
Interest Expense
The following table summarizes the Company’s interest expense:
| | | | | | | | | | | | | | | | | | | | | | |
| | Three Months Ended March 31, | | |
| | 2025 | | 2024 | | | | | | | | |
2021 Senior Notes | | | | | | | | | | | | |
Amortization of debt issuance costs | | $ | 383 | | | $ | 408 | | | | | | | | | |
Interest on borrowings | | 2,542 | | | 2,954 | | | | | | | | | |
Amortization of debt discount | | 28 | | | 26 | | | | | | | | | |
2024 Term Loan: | | | | | | | | | | | | |
Amortization of debt issuance costs | | 384 | | | — | | | | | | | | | |
Amortization of exit fee | | 85 | | | — | | | | | | | | | |
Interest on borrowings | | 1,838 | | | — | | | | | | | | | |
| | | | | | | | | | | | |
Other1 | | 162 | | | 129 | | | | | | | | | |
Total interest expense | | $ | 5,422 | | | $ | 3,517 | | | | | | | | | |
________________________________
1 Includes interest on uncertain tax provisions.
Note 10. Accumulated Other Comprehensive (Loss) / Income
The changes in accumulated other comprehensive (loss) income during the three months ended March 31, 2025 were as follows:
| | | | | | | | | | | | | | | | | | | | | | | |
| Balance at December 31, 2024 | | Other Comprehensive Income | | Tax Effect | | Balance at March 31, 2025 |
Foreign currency | $ | (37,617) | | | $ | 8,853 | | | $ | — | | | $ | (28,764) | |
Unrealized loss on intercompany foreign currency transactions | (3,520) | | | — | | | — | | | (3,520) | |
| | | | | | | |
Total | $ | (41,137) | | | $ | 8,853 | | | $ | — | | | $ | (32,284) | |
Note 11. Capital Structure
As of March 31, 2025, the Company’s authorized capital stock was 26,666,667 shares of stock with a par value of $0.0001, of which 16,666,667 shares were designated as common stock and 10,000,000 shares were designated as preferred stock.
Common Stock
Each holder of common stock is entitled to vote on all matters and is entitled to one vote for each share held. Dividends on common stock will be paid when, and if, declared by the Company’s Board of Directors. No dividends have ever been declared or paid by the Company.
Treasury Stock
The Company’s Treasury Stock balance is nil as of March 31, 2025.
Preferred Stock
The Company’s Board of Directors (the “Board”) is authorized to issue preferred shares and has the discretion to determine the rights, preferences, privileges and restrictions, including voting rights, dividend rights, conversion rights, redemption privileges, and liquidation preferences of preferred stock.
SYNCHRONOSS TECHNOLOGIES, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS — UNAUDITED
(Amounts in tables in thousands, except for per share data or unless otherwise noted)
Series B Non-Convertible Preferred
On June 30, 2021, the Company closed a private placement of 75,000 shares of its Series B Perpetual Non-Convertible Preferred Stock, par value $0.0001 per share, with an initial liquidation preference of $1,000 per share (the “Series B Preferred”), for net proceeds of $72.8 million (the “Series B Transaction”). The sale of the Series B Preferred was pursuant to the Series B Preferred Stock Purchase Agreement, dated as of June 24, 2021 (the “Series B Purchase Agreement”), between the Company and BRPI. In connection with the closing of the Series B Transaction, the Company (i) filed a Certificate of Designation with the State of Delaware setting forth the rights, preferences, privileges, qualifications, restrictions and limitations on the Series B Preferred (the “Series B Certificate”) and (ii) entered into an Investor Rights Agreement with B. Riley Financial, Inc. (“B. Riley Financial”) and BRPI setting forth certain governance and registration rights of B. Riley Financial with respect to the Company.
Repurchase of Series B Preferred
On June 28, 2024 the Company repurchased all outstanding shares of the Series B Preferred stock, as discussed in Note 9. Debt of the Notes to Condensed Consolidated Financial Statements in Item 1 of this Form 10-Q. On July 1, 2024 the Company filed a Certificate of Elimination to the Series B Certificate with the Secretary of State of the State of Delaware. As a result of the Series B Repurchase, no shares of the Series B Preferred remain outstanding and none are authorized for issuance as of March 31, 2025, and the authorized shares of Series B Preferred Stock were returned to the status of authorized but unissued shares of preferred stock of the Company, without designation as to series pursuant to the Certificate of Designations.
Note 12. Stock Plans
As of March 31, 2025, the Company maintains two stock-based compensation plans, the 2015 Equity Incentive Plan (the “2015 Plan”) and the 2017 New Hire Equity Incentive Plan (“2017 Plan”), under which the Company may grant to its employees, outside directors, and consultants awards in the form of stock options, shares of restricted stock, stock units, or stock appreciation rights and performance shares. As of March 31, 2025, the maximum number of shares of common stock authorized for issuance is 5,741,575 shares under the 2015 Plan and 229,635 shares under the 2017 Plan. As of March 31, 2025, there were 45,114 shares available for the grant or award under the Company’s 2015 Plan and 108,382 shares available for the grant or award under the Company’s 2017 Plan.
Stock Options
Stock options granted under the Company’s 2015 and 2017 Plans generally vest one-third of the applicable shares on the first, second, and third anniversary of the grant date, subject to continuous service. The Company accounts for stock options under equity accounting. Stock options are measured at fair value at the grant date using the Black-Scholes option pricing model and expense is recognized on a straight-line basis over the requisite service period. The expense for these awards is recorded in APIC on the Condensed Consolidated Balance Sheets.
Restricted Stock Awards
Restricted stock awards granted under the Company’s 2015 and 2017 Plans generally vest one-third of the applicable shares on the first, second, and third anniversary of the grant date, subject to continuous service. The Company accounts for these awards under equity accounting. Restricted stock awards are measured at the closing stock price at the grant date and expense is recognized on a straight-line basis over the requisite service period. The expense for these awards is recorded in APIC on the Condensed Consolidated Balance Sheets.
Performance-Based Cash Units
Performance-based cash units (“PBCU”) are performance-based awards granted under the Company’s Long Term Incentive (“LTI”) Plans. PBCU are three-year grants tied to specific company performance metrics. Each year, the Compensation Committee establishes performance targets for the applicable performance period and PBCU are earned annually based on the achievement of these targets. All earned PBCU generally vest at the end of a three-year period assuming
SYNCHRONOSS TECHNOLOGIES, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS — UNAUDITED
(Amounts in tables in thousands, except for per share data or unless otherwise noted)
continuous employment as of the vesting date. The PBCU can be settled in cash or in equity as determined by the Compensation Committee, subject to the availability of shares for issuance as of the vesting date.
PBCU that are accounted for as equity awards are measured at the closing stock price at the grant date and expense is recognized on a straight-line basis over the requisite service period. The expense for the period will increase or decrease based on the percentage achievement of the performance metrics at each reporting date. The expense for these awards is recorded in APIC on the Condensed Consolidated Balance Sheets.
PBCU that are accounted for as liability awards are measured at the fair value at the reporting period end date and expense is recognized on a straight-line basis over the requisite service period. The expense for the period will increase or decrease based on updated fair values of these awards as well as the percentage achievement of the performance metrics at each reporting date. The short-term liability related to these awards is included in Accrued expenses and the long-term portion is included in Other liabilities, non-current on the Condensed Consolidated Balance Sheets.
As of March 31, 2025, the Company has three active LTI Plans: 2023-2025 LTI Plan, 2024-2026 LTI Plan and 2025-2027 LTI Plan.
The Company’s PBCU granted to employees under the 2022-2024 LTI Plan were accounted for as equity awards due to Company’s intent and ability to settle them in shares of stock. 246,047 PBCU were earned and distributed in shares of stock upon vesting during the first quarter of 2025.
As of March 31, 2025, the Company’s PBCU granted to employees under the 2023-2025 LTI Plan, 2024-2026 LTI Plan and 2025-2027 LTI Plan have been accounted for as liability awards, due to the Company’s intent and the ability to settle such awards in cash upon vesting and expected lack of shares available for issuance. As of March 31, 2025, the short-term liability for such awards is $0.4 million and the long-term liability is $1.2 million.
SYNCHRONOSS TECHNOLOGIES, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS — UNAUDITED
(Amounts in tables in thousands, except for per share data or unless otherwise noted)
Stock-Based Compensation Expense
The following table summarizes stock-based compensation expense related to all of the Company’s stock awards included by operating expense categories, as follows:
| | | | | | | | | | | | | | | | | | | |
| Three Months Ended March 31, | | |
| 2025 | | 2024 | | | | | | | | |
Cost of revenues | $ | 99 | | | $ | 23 | | | | | | | | | |
Research and development | 539 | | | 223 | | | | | | | | | |
Selling, general and administrative | 1,491 | | | 864 | | | | | | | | | |
Total stock-based compensation expense | $ | 2,129 | | | $ | 1,110 | | | | | | | | | |
The following table summarizes stock-based compensation expense related to all of the Company’s stock awards included by award type, as follows:
| | | | | | | | | | | | | | | | | | | |
| Three Months Ended March 31, | | |
| 2025 | | 2024 | | | | | | | | |
Awards classified as equity: | | | | | | | | | | | |
Stock options | $ | 115 | | | $ | 198 | | | | | | | | | |
Restricted stock awards | 940 | | | 428 | | | | | | | | | |
Performance-based cash units | 381 | | | 463 | | | | | | | | | |
Total equity classified awards | 1,436 | | | 1,089 | | | | | | | | | |
Awards classified as liability: | | | | | | | | | | | |
Performance-based cash units | 693 | | | 21 | | | | | | | | | |
| | | | | | | | | | | |
Total stock-based compensation before taxes | $ | 2,129 | | | $ | 1,110 | | | | | | | | | |
Tax benefit | $ | 470 | | | $ | 252 | | | | | | | | | |
The total unamortized stock-based compensation cost related to unvested restricted stock awards and stock options as of March 31, 2025 was $7.9 million. The expense is expected to be recognized over a weighted-average period of approximately 2.3 years.
The total unamortized stock-based compensation cost related to unvested performance-based cash units as of March 31, 2025 was $4.5 million. The expense is expected to be recognized over a weighted-average period of approximately 2.3 years.
Note 13. Restructuring
The Company continues to identify workforce optimization opportunities to better align the Company’s resources with its key strategic priorities.
A summary of the Company’s restructuring accrual at March 31, 2025 and changes during the three months ended March 31, 2025, are presented below:
| | | | | | |
| | Employee Termination Costs |
Balance at December 31, 2024 | | $ | 712 | |
Charges | | 118 | |
Payments | | (672) | |
| | |
Balance at March 31, 2025 | | $ | 158 | |
SYNCHRONOSS TECHNOLOGIES, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS — UNAUDITED
(Amounts in tables in thousands, except for per share data or unless otherwise noted)
Note 14. Income Taxes
The Company recognized an income tax expense of approximately $1.3 million and $0.6 million during the three months ended March 31, 2025 and 2024, respectively. The effective tax rate was approximately (50.3)% for the three months ended March 31, 2025, which was lower than the U.S. federal statutory rate primarily due to impact of permanent adjustments, including Global Intangible Low-Taxed Income, and valuation allowances recorded, partially offset by the impact of foreign tax rate differential. The Company’s effective tax rate was approximately 11.9% for the three months ended March 31, 2024, which was lower than the U.S. federal statutory rate primarily due to the impact of valuation allowances recorded and foreign tax rate differential, partially offset by projected current income tax expense in the U.S. and certain foreign jurisdictions. The Company continues to consider all available evidence, including historical profitability and projections of future taxable income together with new evidence, both positive and negative, that could affect the view of the future realization of deferred tax assets. As a result of this assessment, the Company continues to record a valuation allowance against the net deferred tax assets of certain jurisdictions as the realization of these assets is not more likely than not, given uncertainty of future earnings in these jurisdictions.
Unrecognized tax benefits associated with uncertain tax positions were $4.4 million at March 31, 2025. We are not able to reasonably estimate when we would make any cash payments required to settle these liabilities, but we do not believe that the ultimate settlement of our obligations will materially affect our liquidity. The Company anticipates that $3.8 million of its currently unrecognized tax benefits, primarily related to research and development credits and other U.S. tax positions, may be recognized within the next 12 months as a result of a lapse of the statute of limitations.
During 2021 the Internal Revenue Service commenced an audit of certain of the Company’s prior year U.S. federal income tax filings, including the 2013 through 2020 tax years. The audit is currently ongoing and is in its concluding stages. While the receipt of the associated refunds would materially improve its financial position, the Company does not believe that the results of this audit will have a material effect on its results of operations. The Company has not accrued for any potential interest income related to the expected tax refund as of March 31, 2025.
The Pillar Two Global Anti-Base Erosion rules issued by the Organization for Economic Co-operation and Development ("OECD"), a global policy forum, introduced a global minimum tax of 15% which would apply to multinational groups with consolidated financial statement revenue in excess of EUR 750 million. Nearly all OECD member jurisdictions have agreed in principle to adopt these provisions and numerous jurisdictions, including jurisdictions where the Company operates, have enacted these rules effective January 1, 2024. The Company is not currently subject to these rules but is continuing to evaluate the Pillar Two Framework and its potential impact on future periods.
Note 15. Earnings per Common Share (“EPS”)
Basic EPS is computed based upon the weighted average number of common shares outstanding for the year. Diluted EPS is computed based upon the weighted average number of common shares outstanding for the year plus the dilutive effect of common stock equivalents using the treasury stock method and the average market price of the Company’s common stock for the year. The Company includes participating securities (such as performance-based cash unit awards) in the computation of EPS pursuant to the two-class method. The two-class method of computing earnings per share is an allocation method that calculates earnings per share for common stock and participating securities. During periods of net loss, no effect is given to the participating securities because they do not share in the losses of the Company.
SYNCHRONOSS TECHNOLOGIES, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS — UNAUDITED
(Amounts in tables in thousands, except for per share data or unless otherwise noted)
The following table provides a reconciliation of the numerator and denominator used in computing basic and diluted net income attributable to common stockholders per common share from operations.
| | | | | | | | | | | | | | | | | | | |
| Three Months Ended March 31, | | |
| 2025 | | 2024 | | | | | | | | |
Numerator - Basic: | | | | | | | | | | | |
Net (loss) income | $ | (3,817) | | | $ | 4,475 | | | | | | | | | |
Net loss attributable to redeemable non-controlling interests | — | | | (5) | | | | | | | | | |
Preferred stock dividend | — | | | (2,129) | | | | | | | | | |
Net (loss) income attributable to Synchronoss | (3,817) | | | 2,341 | | | | | | | | | |
| | | | | | | | | | | |
| | | | | | | | | | | |
| | | | | | | | | | | |
| | | | | | | | | | | |
Numerator - Diluted: | | | | | | | | | | | |
Net (loss) income attributable to Synchronoss | (3,817) | | | 2,341 | | | | | | | | | |
| | | | | | | | | | | |
| | | | | | | | | | | |
| | | | | | | | | | | |
| | | | | | | | | | | |
Net (loss) income attributable to Synchronoss | $ | (3,817) | | | $ | 2,341 | | | | | | | | | |
| | | | | | | | | | | |
Denominator: | | | | | | | | | | | |
Weighted average common shares outstanding — basic | 10,201 | | | 9,842 | | | | | | | | | |
Dilutive effect of: | | | | | | | | | | | |
| | | | | | | | | | | |
| | | | | | | | | | | |
Shares from assumed conversion of PBCU | — | | | 277 | | | | | | | | | |
Options and unvested restricted shares | — | | | 158 | | | | | | | | | |
Weighted average common shares outstanding — diluted | $ | 10,201 | | | $ | 10,277 | | | | | | | | | |
| | | | | | | | | | | |
| | | | | | | | | | | |
Earnings (loss) per share: | | | | | | | | | | | |
| | | | | | | | | | | |
| | | | | | | | | | | |
| | | | | | | | | | | |
Basic | $ | (0.37) | | | $ | 0.24 | | | | | | | | | |
| | | | | | | | | | | |
| | | | | | | | | | | |
| | | | | | | | | | | |
| | | | | | | | | | | |
Diluted | $ | (0.37) | | | $ | 0.23 | | | | | | | | | |
| | | | | | | | | | | |
| | | | | | | | | | | |
Anti-dilutive stock options and restricted stock awards1 | 459 | | | 627 | | | | | | | | | |
| | | | | | | | | | | |
________________________________
1 Represent stock options and restricted stock awards excluded from the Diluted EPS calculations because the effect would be anti-dilutive.
SYNCHRONOSS TECHNOLOGIES, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS — UNAUDITED
(Amounts in tables in thousands, except for per share data or unless otherwise noted)
Note 16. Commitments
Non-cancelable Agreements
The Company has various non-cancelable arrangements such as services for hosting, support, and software that expire at various dates, with the latest expiration in 2028.
Aggregate annual future minimum payments under non-cancelable agreements as of March 31, 2025 for each year subsequent to December 31, 2024 and thereafter, are as follows:
| | | | | | | | | | | | |
| | Non-cancelable Agreements | | | | |
2025 | | $ | 15,242 | | | | | |
2026 | | 3,431 | | | | | |
2027 | | 1,903 | | | | | |
2028 | | 142 | | | | | |
| | | | | | |
Total | | $ | 20,718 | | | | | |
Note 17. Legal Matters
In the ordinary course of business, the Company is regularly subject to various claims, suits, regulatory inquiries and investigations. The Company records a liability for specific legal matters when it determines that the likelihood of an unfavorable outcome is probable, and the loss can be reasonably estimated. Management has also identified certain other legal matters where they believe an unfavorable outcome is not probable and, therefore, no reserve is established. Although management currently believes that resolving claims against the Company, including claims where an unfavorable outcome is reasonably possible, will not have a material impact on the Company’s business, financial position, results of operations, or cash flows, these matters are subject to inherent uncertainties and management’s view of these matters may change in the future. The Company also evaluates other contingent matters, including income and non-income tax contingencies, to assess the likelihood of an unfavorable outcome and estimated extent of potential loss. It is possible that an unfavorable outcome of one or more of these lawsuits or other contingencies could have a material impact on the liquidity, results of operations, or financial condition of the Company.
In the third quarter of 2017, the SEC and Department of Justice (the “DoJ”) initiated investigations in connection with certain financial transactions that the Company effected in 2015 and 2016 and its disclosure of and accounting for such transactions, which the Company restated in the third quarter of 2018 in its restated annual and quarterly financial statements for 2015 and 2016. On June 7, 2022 the SEC approved the Offer of Settlement and filed an Order Instituting Cease-And-Desist Proceedings pursuant to Section 21C of the Securities Exchange Act of 1934, Making Findings, and Imposing a Cease-And-Desist Order (the “SEC Order”). Pursuant to the terms of the SEC Order, the Company consented to pay a civil penalty in the amount of $12.5 million in equal quarterly installments over two years and to cease and desist from committing or causing any violations of Sections 10(b), 13(a), 13(b)(2)(A) and 13(b)(2)(B) of the Exchange Act and the associated rules thereunder. Failure to comply with the provisions of the SEC Order could result in further actions by one or both governmental agencies which could have a material adverse effect on the Company’s results of operations. The penalties have been paid in full as of March 31, 2024. Also on June 7, 2022, the SEC filed a civil action against two former members of the Company’s management team (the “defendants”), alleging misconduct arising out of certain of the restated transactions that took place in 2015 and 2016 investigated by the SEC as set forth above. During the second quarter of 2024, the Court entered final judgments in both of these civil actions pursuant to which the defendants agreed to pay civil penalties totaling an aggregate of $145,000 and one defendant agreed to disgorge incentive compensation received during the period of the restated transactions in the amount of $430,741. The Company has indemnified the defendants in these actions for certain costs and expenses, including reasonable attorney’s fees. During the quarter ended March 31, 2024, the Company reimbursed the defendants for the remaining costs and expenses, and as of March 31, 2025, no additional amounts are owed pursuant to this indemnification obligation.
SYNCHRONOSS TECHNOLOGIES, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS — UNAUDITED
(Amounts in tables in thousands, except for per share data or unless otherwise noted)
The Company is not currently subject to any other legal proceedings that would be expected to have a material adverse effect on its operations; however, the Company may from time to time become a party to various legal proceedings arising in the ordinary course of its business.
Note 18. Additional Financial Information
Other Income (Expense)
The following table sets forth the components of Other Income (expense), net included in the Condensed Consolidated Statements of Operations:
| | | | | | | | | | | | | | | | | | | | |
| | Three Months Ended March 31, | | |
| | 2025 | | 2024 | | | | | | |
Foreign exchange gains (losses) | | $ | (5,579) | | | $ | 3,801 | | | | | | | |
| | | | | | | | | | |
| | | | | | | | | | |
| | | | | | | | | | |
Other1 | | — | | | 10 | | | | | | | |
Total | | $ | (5,579) | | | $ | 3,811 | | | | | | | |
________________________________1 Represents an aggregate of individually immaterial transactions.
The non-cash impact of the foreign exchange gains and losses on intercompany payables and receivables is reflected as an adjustment to reconcile the Net income to cash within the Other, net line item in the operating activities, as reported on the Condensed Consolidated Statements of Cash Flows.
Note 19. Subsequent Events
On April 24, 2025 (the “Closing Date”), Synchronoss Technologies Inc. (the “Synchronoss”) and certain of its subsidiaries (together with Synchronoss, the “Companies”) entered into that certain First Amendment to Credit Agreement and Pledge and Security Agreement (the “Amendment”) with the lenders party thereto and BGC Lender Rep LLC, as administrative agent (the “Administrative Agent”), which amended (i) that certain Credit Agreement, dated as of June 28, 2024 (the “Credit Agreement”, and as amended by the Amendment, the “Amended Credit Agreement”), among Synchronoss, the lenders party thereto from time to time and the Administrative Agent and (ii) that certain Pledge and Security Agreement, dated as of June 28, 2024 (the “Security Agreement”, and as amended by the Amendment, the “Amended Security Agreement”), among the Companies and the Administrative Agent.
On the Closing Date, the Amended Credit Agreement established a new term loan facility in an aggregate principal amount of $200 million (the “First Amendment Loan”), with any existing lenders under the Credit Agreement participating pursuant to a cashless settlement of the $73.6 million outstanding aggregate principal amount of term loan facility under the Credit Agreement. Synchronoss intends to use proceeds from the First Amendment Loan, together with cash on hand, to redeem all of the $121 million outstanding aggregate principal amount of senior notes on or around May 12, 2025 at the applicable redemption price, as previously disclosed.
The First Amendment Loans will mature on April 24, 2029 (subject to a springing maturity of nine months prior to the date of cancellation of certain material contracts if unreplaced in accordance with the terms of the Amended Credit Agreement) and bear an interest rate of the secured overnight financing rate, which shall not be less than 2.50%, plus a margin of 7.00% per annum (with one 0.50% stepdown at specified leverage). The First Amendment also includes (i) a covenant tested quarterly which limits the consolidated secured leverage ratio to 6.30 to 1.00 or under, (ii) a covenant tested monthly with respect to a minimum number of subscribers under certain material contracts and (iii) certain other changes to the terms of the Credit Agreement, including with respect to certain negative covenants.
ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
Management’s Discussion and Analysis of Financial Condition and Results of Operations (“MD&A”) is intended to provide a reader of our financial statements with a narrative from the perspective of our management on our financial condition, results of operations, liquidity and certain other factors that may affect our future results. The following discussion and analysis should be read in conjunction with our Condensed Consolidated Financial Statements and the related notes included in Item 1 “Financial Information” of this Form 10-Q.
Forward-looking Statements
This Quarterly Report on Form 10-Q, as well as information included in oral statements or other written statements made or to be made by us, contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, that involve substantial risks and uncertainties. All statements other than statements of historical fact contained in this report, including statements regarding our future results of operations and financial condition, business strategy, and plans and objectives of management for future operations, are forward-looking statements. In some cases, forward-looking statements may be identified by words such as “believe,” “may,” “will,” “potentially,” “estimate,” “continue,” “anticipate,” “intend,” “should,” “could,” “would,” “project,” “target,” “plan,” “expect,”, “seek,” “hope,” “likely,” or the negative of these terms or other similar expressions.
Forward-looking statements are based on our management’s beliefs and assumptions and on information currently available. These forward-looking statements are subject to a number of known and unknown risks, uncertainties and assumptions, including risks described in the section titled “Risk Factors” and elsewhere in this Quarterly Report on Form 10-Q that may cause actual results to differ materially from those anticipated or implied by the forward-looking statements. These factors include, but are not limited to:
•Adverse changes in the national and global economic environments, including foreign currency exchange and tariffs could affect our sales, revenue and profitability;
•Changes in market trends, growth rates and consumer preferences could impact our ability to meet customer demands, launch new products or features successfully, attract and retain new customers, or to successfully compete with other providers of similar products;
•New laws, regulations or changes to existing laws or regulations, including economic and trade policy, taxation and data protection, could increase our operational complexity or cost;
•Failure to anticipate and keep up with technological advancements could impair our competitiveness;
•Security breaches or cyber-attacks could compromise our proprietary information, cause reputational harm and result in financial penalties;
•The sufficiency of and our ability access cash or cash equivalents to meet our liquidity needs, the timing of our federal tax refund, capital expenditures, fluctuations in interest rates or credit availability could impact our financial performance;
•Legal proceedings or changes in the legal environment could affect our business operations and financial condition;
•Pandemic outbreaks, geopolitical tensions or natural disasters could disrupt our operations;
•Our ability to attract and retain talented employees is crucial to our success and any shortfall in that area could impact our operations.
Given these risks and uncertainties, undue reliance should not be placed on such forward-looking statements. Moreover, we operate in a very competitive and rapidly changing environment. New risk factors emerge from time to time, and it is not possible for our management to predict all risk factors, nor can we assess the impact of all factors on our business or the extent to which any factor, or combination of factors, may cause actual results to differ from those contained in, or implied by, any forward-looking statements. Except as required by law, we undertake no obligation to update publicly any forward-looking statements for any reason after the date of this report or to conform these statements to actual results or to changes in our expectations. You should read this Quarterly Report on Form 10-Q and the documents that we have filed as exhibits to this report with the understanding that our actual future results, levels of activity, performance, and achievements may be materially different from what we expect. We qualify all of our forward-looking statements by these cautionary statements.
Investors, the media, and others should note that we intend to announce material information to the public through filings with the Securities and Exchange Commission (SEC), the investor relations page on our website (https://
synchronosstechnologiesinc.gcs-web.com/), press releases, public conference calls, webcasts and social media channels, including our X (formerly known as Twitter) feed (x.com/synchronoss) and LinkedIn page (https://www.linkedin.com/company/synchronoss-technologies). The information disclosed by the foregoing channels could be deemed to be material information. As such, we encourage investors, the media, and others to follow the channels listed above and to review the information disclosed through such channels. Any updates to the list of disclosure channels through which we will announce information will be posted on the investor relations page on our website. The contents of the websites provided above are not incorporated into this filing or in any other report or document we file with the SEC. These website addresses are intended to be inactive textual references only.
Overview
Synchronoss Technologies, Inc. (“Synchronoss” or the “Company”) is a leading provider of white label cloud software and services that enable our customers to keep subscribers, systems, networks, and content in sync.
The Synchronoss Personal CloudTM platform is a secure and highly scalable white label platform that allows our customers’ subscribers to backup and protect, engage with, and manage their personal content and gives our operator customers the ability to increase average revenue per user (“ARPU”) and reduce churn.
Designed for smartphones, tablets, and desktops across all operating systems, our platform ensures a seamless cross-device experience.
We market our solutions through multiple channels such as our corporate website, direct sales teams across key regions (North America, Europe, Middle East and Africa (“EMEA”) and Asia-Pacific (“APAC”)), and industry partnerships.
Revenues
We generate most of our revenues on a subscription basis, which is derived from customer contracts with terms ranging from three to five years.
The future success of our business depends on the continued growth of B2B and Business-to-Business-to-Consumer driving customer transactions, and continued expansion of our platforms into the telecom (“TMT”) market globally through cloud markets. As such, the volume of subscribers and our ability to expand our footprint in TMT and globally may result in revenue fluctuations on a quarterly basis.
Most of our revenues are recorded in U.S. dollars, but as we continue to expand our footprint with international carriers, we are subject to currency translation that could affect our future net sales as reported in U.S. dollars.
The Company’s top five customers accounted for 99.1% and 97.2% of net revenues for the three months ended March 31, 2025 and March 31, 2024, respectively. Contracts with these customers typically run for three to five years. Of these customers, both Verizon and AT&T accounted for more than 10% of our revenues in 2025 and 2024. The loss of Verizon or AT&T as a customer would have a material negative impact on our company. However, we believe the costs incurred by and subscriber disruption for Verizon or AT&T to replace Synchronoss’ solutions would be substantial.
Current Trends Affecting Our Results of Operations
Business from our Synchronoss Personal Cloud™ solution has been driven by the growth in mobile devices globally that are becoming content rich. As these devices replace other traditional devices like PCs, the ability to securely back up content from mobile devices, sync it with other devices and share it with family, friends and business associates has become an essential need and subscriber expectation. Such devices include smartphones, connected cars, personal health and wellness devices, and connected home devices. The need for the content from these devices to be stored in a common cloud is also expected to drive our business in the longer term.
Discussion of the Condensed Consolidated Statements of Operations
The following table presents an overview of our results of operations for the three months ended March 31, 2025 and 2024 (in thousands):
| | | | | | | | | | | | | | | | | | | | | | | | |
| | Three Months Ended March 31, | | Change | | |
| | 2025 | | 2024 | | | | 2025 vs 2024 | | |
Net revenues | | $ | 42,213 | | | $ | 42,965 | | | | | $ | (752) | | | |
Cost of revenues1 | | 8,711 | | | 10,223 | | | | | (1,512) | | | |
Research and development | | 9,698 | | | 10,331 | | | | | (633) | | | |
Selling, general and administrative | | 11,379 | | | 13,257 | | | | | (1,878) | | | |
Restructuring charges | | 118 | | | 219 | | | | | (101) | | | |
Depreciation and amortization | | 4,078 | | | 4,359 | | | | | (281) | | | |
Total costs and expenses | | 33,984 | | | 38,389 | | | | | (4,405) | | | |
Income from operations | | 8,229 | | | 4,576 | | | | | 3,653 | | | |
Interest income | | 233 | | | 208 | | | | | 25 | | | |
Interest expense | | (5,422) | | | (3,517) | | | | | (1,905) | | | |
| | | | | | | | | | |
Other (expense) income, net | | (5,579) | | | 3,811 | | | | | (9,390) | | | |
| | | | | | | | | | |
(Loss) income from operations, before taxes | | (2,539) | | | 5,078 | | | | | (7,617) | | | |
Provision for income taxes | | (1,278) | | | (603) | | | | | (675) | | | |
Net (loss) income | | $ | (3,817) | | | $ | 4,475 | | | | | $ | (8,292) | | | |
________________________________
1 Cost of revenues excludes depreciation and amortization which are shown separately.
Net revenues decreased $0.8 million to $42.2 million for the three months ended March 31, 2025, compared to the same period in 2024. The decrease in revenue was primarily attributable to a decline in professional services revenue in the current year associated with the termination of certain contracts in 2024.
Cost of revenues decreased $1.5 million to $8.7 million for the three months ended March 31, 2025, compared to the same period in 2024. The decrease in 2025 was primarily due to lower baseline employee expenses resulting from restructuring measures implemented in the fourth quarter of 2024, as well as cost-saving initiatives aimed at reducing vendor expenditures and overhead.
Research and development expense decreased $0.6 million to $9.7 million for the three months ended March 31, 2025, compared to the same period in 2024. The decrease in 2025 was primarily attributable to cost-saving initiatives implemented in the fourth quarter of 2024 aimed at streamlining the workforce and reducing vendor expenditures.
Selling, general and administrative expense decreased $1.9 million to $11.4 million for the three months ended March 31, 2025, compared to the same period in 2024. The decrease in 2025 was primarily attributable to cost-saving initiatives implemented in the fourth quarter of 2024 aimed at streamlining the workforce and reducing vendor expenditures.
Restructuring charges were $0.1 million for the three months ended March 31, 2025 and $0.2 million for the three months ended March 31, 2024. Restructuring charges were primarily related to employment termination costs as a result of the work-force reductions initiated to reduce operating costs and align our resources with our key strategic priorities.
Depreciation and amortization expense decreased $0.3 million for the three months ended March 31, 2025, compared to the same period in 2024. The 2025 decrease was primarily attributable to the reduced amortization of capitalized software.
Interest income increased immaterially for the three months ended March 31, 2025, compared to the same period in prior year. Interest income is mainly related to interest on India's Unitized Time Deposits (UTDs).
Interest expense increased $1.9 million to $5.4 million for the three months ended March 31, 2025, compared to the same period in 2024. The increase is mainly due to $1.8 million interest expense related to the new Term Loan the Company obtained at the end of the second quarter of 2024, which was used to retire the Series B Preferred stock, improving the Company’s overall capital structure.
Other income (expense), net decreased $9.4 million to expense of $5.6 million for the three months ended March 31, 2025 from income of $3.8 million during the same period in 2024 primarily due to the impact of non-cash foreign exchange losses on intercompany payables and receivables.
Income tax. The Company recognized an income tax expense of approximately $1.3 million for the three months ended March 31, 2025 and $0.6 million for the three months ended March 31, 2024. The effective tax rate was approximately (50.3)% for the three months ended March 31, 2025, which was lower than the U.S. federal statutory rate primarily due to impact of permanent adjustments, including Global Intangible Low-Taxed Income, and valuation allowances recorded, partially offset by the impact of foreign tax rate differential. The Company’s effective tax rate was approximately 11.9% for the three months ended March 31, 2024, which was lower than the U.S. federal statutory rate primarily due to the impact of valuation allowances recorded and foreign tax rate differential, partially offset by projected current income tax expense in the U.S. and certain foreign jurisdictions.
Liquidity and Capital Resources
Our principal sources of liquidity have been cash provided by operations. At March 31, 2025 the Company had an aggregate of $29.1 million cash and cash equivalents, and generated operating cash flows of $0.3 million for the three months ended March 31, 2025. At March 31, 2025, our non-U.S. subsidiaries held approximately $12.1 million of cash and cash equivalents that are available for use by our operations around the world. The Company believes it has sufficient cash and cash equivalents and will generate sufficient liquidity from operations to meet its obligations for at least the next 12 months.
Our policy has been to leave our cumulative unremitted foreign earnings invested indefinitely outside the United States, and we intend to continue this policy for most of our foreign subsidiaries. During 2023, we changed our indefinite reinvestment assertion for our Indian subsidiary and recorded a deferred tax liability associated with the outside basis difference. The Company continues to assert permanent reinvestment of foreign earnings in all other foreign jurisdictions. Due to the timing and circumstances of repatriation of such earnings, if any, it is not practicable to determine the unrecognized deferred tax liability relating to such amounts.
We believe that our cash, cash equivalents, financing sources, and our ability to manage working capital and expected positive cash flows generated from operations in combination with continued expense reductions will be sufficient to fund our operations for the next twelve months from the filing date of this Form 10-Q. However, as the current geopolitical tensions unfold, we will continue to assess any impact on our operations and our liquidity needs. Our liquidity plans are subject to a number of risks and uncertainties, including those described in the "Forward-Looking Statements" section of this MD&A and Part I, Item 1A. “Risk Factors” in our Annual Report on Form 10-K for the year ended December 31, 2024, some of which are outside of our control.
Discussion of Cash Flows
A summary of net cash flows follows (in thousands): | | | | | | | | | | | | | | | | | |
| Three Months Ended March 31, | | | | | | |
| 2025 | | 2024 | | | | | | |
Net cash provided by (used in): | | | | | | | | | |
Operating activities | $ | 293 | | | $ | 527 | | | | | | | |
Investing activities | (3,310) | | | (3,803) | | | | | | | |
Financing activities | $ | (1,278) | | | $ | (2,129) | | | | | | | |
Our primary source of cash is receipts from revenue. The primary uses of cash are personnel and related costs, telecommunications, and facility costs related primarily to our cost of revenue and general operating expenses including professional service fees, consulting fees, building and equipment maintenance and marketing expense.
Cash provided by operating activities for the three months ended March 31, 2025 was $0.3 million as compared to $0.5 million of cash provided by operating activities for the same period in 2024. In the current period, the Company generated cash from operations mainly driven by continued growth in cloud subscribers and reduced operating costs, offset by unfavorable movements in working capital compared to the first quarter of 2024.
Cash used in investing activities for the three months ended March 31, 2025 was $3.3 million as compared to $3.8 million of cash used in investing activities during the same period in 2024. The cash used in investing activities during current and prior year primarily funded product development for our Cloud offering and associated labor costs.
Cash used in financing activities for the three months ended March 31, 2025 was $1.3 million as compared to $2.1 million of cash used in financing activities during the same period in 2024. The cash used in financing activities in the current year was primarily related to the $0.5 million principal payment on the Term Loan and $0.8 million of income and payroll taxes paid as a result of stock-based withholding. Cash used in financing activities in the prior year was primarily related to $2.1 million dividend payment on Series B Preferred stock.
Effect of Inflation
Inflationary increases in certain input costs, such as occupancy, labor and benefits, and general administrative costs have impacted our business. Management does not believe these impacts have had a material impact on our results of operations during the three months ended March 31, 2025 and 2024. We cannot assure you, however, that we will not be affected by general inflation in the future.
Contractual Obligations
Our contractual obligations consist of office and laptop leases, notes payable and related interest as well as contractual commitments under third-party hosting, software licenses and maintenance agreements. The following table summarizes our long‑term contractual obligations as of March 31, 2025 (in thousands):
| | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | Payments Due by Period |
| | Total | | 2025 | | 2026-2027 | | 2028 | | |
Finance lease obligations | | $ | 1,538 | | | $ | 733 | | | $ | 805 | | | $ | — | | | |
Interest | | 36,057 | | | 13,154 | | | 18,667 | | | 4,236 | | | |
Operating lease obligations | | 23,752 | | | 5,683 | | | 13,793 | | | 4,276 | | | |
Purchase obligations1 | | 20,718 | | | 15,242 | | | 5,334 | | | 142 | | | |
Senior Notes Payable | | 121,387 | | | — | | | 121,387 | | | — | | | |
Term Loan | | 73,594 | | | 1,406 | | | 12,188 | | | 60,000 | | | |
| | | | | | | | | | |
Total | | $ | 277,046 | | | $ | 36,218 | | | $ | 172,174 | | | $ | 68,654 | | | |
_______________________________
1 Amount represents obligations associated with colocation agreements and other customer delivery related purchase obligations.
Uncertain Tax Positions
Unrecognized tax benefits associated with uncertain tax positions were $4.4 million at March 31, 2025. We are not able to reasonably estimate when we would make any cash payments required to settle these liabilities, but we do not believe that the ultimate settlement of our obligations will materially affect our liquidity. The Company anticipates that $3.8 million of its currently unrecognized tax benefits, primarily related to research and development credits and other U.S. tax positions, may be recognized within the next 12 months as a result of a lapse of the statute of limitations.
Critical Accounting Policies and Estimates
Our condensed consolidated financial statements and accompanying notes have been prepared in accordance with U.S. GAAP. The preparation of these condensed consolidated financial statements in accordance with U.S. GAAP requires us to utilize accounting policies and make certain estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingencies as of the date of the financial statements and the reported amounts of revenues and expenses during a fiscal period.
The SEC considers an accounting policy to be critical if it is important to a company’s financial condition and results of operations, and if it requires significant judgment and estimates on the part of management in its application. These estimates and assumptions take into account historical and forward looking factors that the Company believes are reasonable, including but not limited to the potential impacts from current geopolitical tensions. As the extent and duration of the impacts from geopolitical developments remain unclear, the Company’s estimates and assumptions may evolve as conditions change. Actual results could differ significantly from those estimates. If actual results or events differ materially from those contemplated by us in making these estimates, our reported financial condition and results of operations for future periods could be materially affected.
During the three months ended March 31, 2025, there were no significant changes in our critical accounting policies and estimates from our Annual Report on Form 10-K for the year ended December 31, 2024. Refer to Management’s Discussion and Analysis of Financial Condition and Results of Operations contained in Part II, Item 7 of our Annual Report on Form 10-K for the year ended December 31, 2024 for a more complete discussion of our critical accounting policies and estimates.
Recently Issued Accounting Standards
For a discussion of recently issued accounting standards see Note 2. Basis of Presentation and Consolidation of the Notes to Condensed Consolidated Financial Statements in Item 1 of this Form 10-Q.
Off-Balance Sheet Arrangements
We had no off-balance sheet arrangements as of March 31, 2025 and December 31, 2024 that have, or are reasonably likely to have, a current or future effect on our financial condition, changes in financial condition, revenues or expenses, results of operations, liquidity, capital expenditures or capital resources that are material to investors.
ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK
Market Risk
The following discussion about market risk involves forward-looking statements. Actual results could differ materially from those projected in the forward-looking statements. We deposit our excess cash in what we believe are high-quality financial instruments, primarily money market funds and certificates of deposit, and we may be exposed to market risks related to changes in interest rates. These investments are denominated in United States dollars.
The primary objective of our investment activities is to preserve our capital for the purpose of funding operations, while at the same time maximizing the income we receive from our investments without significantly increasing risk. To achieve these objectives, our investment policy allows us to maintain a portfolio of cash equivalents and short- and long-term investments in a variety of securities, which could include commercial paper, money market funds and corporate and government debt securities. Our cash and cash equivalents at March 31, 2025 and December 31, 2024 were invested in liquid money market accounts and certificates of deposit. All market-risk sensitive instruments were entered into for non-trading purposes.
Foreign Currency Exchange Risk
We are exposed to translation risk because certain of our foreign operations utilize the local currency as their functional currency and those financial results must be translated into U.S. dollars. As currency exchange rates fluctuate, translation of the financial statements of foreign businesses into U.S. dollars affects the comparability of financial results between years.
We do not hold any derivative instruments and do not engage in any hedging activities. Although our reporting currency is the U.S. dollar, we may conduct business and incur costs in the local currencies of other countries in which we may operate, make sales and buy materials and services. As a result, we are subject to foreign currency transaction risk. Further, changes in exchange rates between foreign currencies and the U.S. dollar could affect our future net sales, cost of sales and expenses, and could result in foreign currency transaction gains or losses.
We cannot accurately predict future exchange rates or the overall impact of future exchange rate fluctuations on our business, results of operations and financial condition. To the extent that our international activities recorded in local currencies increase in the future, our exposure to fluctuations in currency exchange rates will correspondingly increase and hedging activities may be considered if appropriate.
Interest Rate Risk
We are exposed to the risk of interest rate fluctuations on the interest income earned on our cash and cash equivalents. A hypothetical 100 basis point movement in interest rates applicable to our cash and cash equivalents outstanding at March 31, 2025 would increase interest income by approximately $0.3 million on an annual basis.
Borrowings pursuant to our Term Loan Credit Agreement bear interest at a rate per annum equal to the Adjusted Term SOFR (as defined in the Credit Agreement) for the applicable interest period, plus 5.50%, subject to a floor of 2.50%. As such, our net income is sensitive to movements in interest rates. If interest rates increase, our debt obligations pursuant to the Credit Agreement would increase even though the amount borrowed remained the same, and our net income would decrease. Such increases in interest rates could have a material adverse effect on our cash flow and financial condition. We do not hold any derivative instruments and do not engage in any hedging activities to mitigate interest rate risk. Based on our outstanding borrowings pursuant to the Credit Agreement as of March 31, 2025 a hypothetical 100 basis point movement in interest rates would have affected interest expense on the debt by $0.7 million on an annual basis.
ITEM 4. CONTROLS AND PROCEDURES
Evaluation of Disclosure Controls and Procedures
Our Chief Executive Officer and Chief Financial Officer have evaluated the effectiveness of the registrant’s disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) of the Securities Exchange Act of 1934), as of the end of the period covered by this quarterly report, that ensure that information relating to the registrant which is required to be disclosed in this report is recorded, processed, summarized and reported within required time periods using the criteria for effective internal control established in Internal Control-Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission in 2013. Based on this evaluation, our Chief Executive Officer and Chief Financial Officer have concluded that the registrant’s disclosure controls and procedures were effective as of March 31, 2025.
Changes in Internal Control Over Financial Reporting
There were no changes in our internal control over financial reporting (as defined in Rule 13a-15(f) and Rule 15d-15(f) under the Exchange Act) identified in connection with the evaluation of our controls performed during the three months ended March 31, 2025 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.
Limitations on Effectiveness of Controls and Procedures
In designing and evaluating the disclosure controls and procedures and internal control over financial reporting, management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives. In addition, the design of disclosure controls and procedures and internal control over financial reporting must reflect the fact that there are resource constraints and that management is required to apply judgment in evaluating the benefits of possible controls and procedures relative to their costs.
PART II – OTHER INFORMATION
ITEM 1. LEGAL PROCEEDINGS
For a discussion of our material pending legal proceedings that could impact our results of operations, financial condition or cash flows see Note 17. Legal Matters of the Notes to Condensed Consolidated Financial Statements in Item 1 of this Form 10-Q.
ITEM 1A. RISK FACTORS
There have been no material changes to our risk factors as previously disclosed in Part I, Item 1A. included in our Annual Report on Form 10-K for the year ended December 31, 2024.
ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS
None.
ITEM 3. DEFAULTS UPON SENIOR SECURITIES
None.
ITEM 4. MINE SAFETY DISCLOSURES
Not Applicable.
ITEM 5. OTHER INFORMATION
Rule 10b5-1 Trading Plans
During the period covered by this Quarterly Report on Form 10-Q, no director or officer of the Company “adopted” or terminated a “Rule 10b5-1 trading arrangement” or “non-Rule 10b5-1 trading arrangement” as each term is defined in Item 408(a) of Regulation S-K.
ITEM 6. EXHIBITS
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | Incorporated by Reference | | |
Exhibit No. | | Description | | Form | | File No. | | Exhibit | | Filing Date | | Filed Herewith |
3.1 | | | | 10-K | | 001-40574 | | 3.1 | | March 15, 2023 | | |
3.2 | | | | 8-K | | 001-40574 | | 3.1 | | June 23, 2022 | | |
3.3 | | | | S-1 | | 333-132080 | | 3.4 | | May 9, 2006 | | |
3.4 | | | | 8-K | | 000-52049 | | 3.2 | | February 20, 2018 | | |
3.5 | | | | 8-K | | 000-52049 | | 3.3 | | June 30, 2021 | | |
3.6 | | | | 8-K | | 000-52049 | | 3.1 | | June 30, 2021 | | |
3.7 | | | | 8-K | | 001-40574 | | 3.1 | | December 7, 2023 | | |
3.8 | | | | 8-K | | 001-40574 | | 3.1 | | July 1, 2024 | | |
10.1 | | | | 10-Q | | 001-40574 | | 10.1 | | November 12, 2024 | | |
31.1 | | | | | | | | | | | | X |
31.2 | | | | | | | | | | | | X |
32.1 | | | | | | | | | | | | X |
32.2 | | | | | | | | | | | | X |
101.INS | | XBRL Instance Document | | | | | | | | | | X |
101.SCH | | XBRL Schema Document | | | | | | | | | | X |
101.CAL | | XBRL Calculation Linkbase Document | | | | | | | | | | X |
101.DEF | | XBRL Taxonomy Extension Definition Linkbase | | | | | | | | | | X |
101.LAB | | XBRL Labels Linkbase Document | | | | | | | | | | X |
101.PRE | | XBRL Presentation Linkbase Document | | | | | | | | | | X |
| | | | | | | | | | | | |
| | | | | | | | | | | | |
SIGNATURES
Pursuant to the requirements of Securities Exchange Act of 1934, the registrant has caused this Report to be signed on its behalf by the undersigned, thereunto duly authorized.
| | | | | | | | | | | |
| | Synchronoss Technologies, Inc. | |
| | | |
| | | |
| | | |
| | /s/ Jeff Miller | |
| | Jeff Miller | |
| | Chief Executive Officer | |
| | (Principal Executive Officer)
| |
| | | |
| | | |
| | /s/ Louis Ferraro | |
| | Louis Ferraro | |
| | Chief Financial Officer | |
May 6, 2025